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ABSTRACT 
Feline Calicivirus (FCV) is one of the most common causes of upper 
respiratory tract disease in cats. Other disease syndromes associated with 
FCV infection have been reported. Recently, calicivirus infections 
associated with a hemorrhagic-like disease leading to significant mortality in 
cats has been reported. The clinical signs are similar to those observed with 
the Calicivirus of Rabbit Hemorrhagic Disease. This investigation 
characterized two FCV isolates associated with hemorrhagic-like disease. 
Nucleotide sequencing of the complete genome was done on these two 
isolates and four isolates representing other disease syndromes. Previously 
reported sequence data for the entire genome of classical FCV (six isolates) 
and a portion of the capsid gene for hemorrhagic-like FCV (three isolates) 
were used in the genetic analysis. Sequence data were used to determine 
relationships among the isolates and any correlates with phenotype. 
Nucleotide sequence comparisons of the entire genome and individual 
ORF’s revealed high homology among all isolates. However, data from this 
study suggest that the virulence may have genetic determinants as revealed 
by phylogenetic clustering based on a specific 75 nucleotides stretch from 
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the capsid protein gene of the isolates associated with hemorrhagic-like 
disease. 
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I-Introduction 
Feline calicivirus (FCV) is an important pathogen of cats, producing a 
wide range of clinical diseases, the most important of which is acute upper 
respiratory tract disease 32. Clinical signs associated with infection include 
ocular discharge, nasal discharge, lingual ulcers,109 chronic gingivitis, 
pharyngitis,149 chronic stomatitis,146 and pneumonia 109. Other disease 
manifestations have been reported and include jaundice, death from in 
utero39, and acute arthritis  32,101. Existence of a carrier state is not uncommon 
157,159. Recently, a virulent calicivirus- associated, systemic hemorrhagic 
disease with significant mortality has occurred in cat populations in the 
United States 61,100,130. This latter disease is similar to rabbit hemorrhagic 
disease caused by a calicivirus (genus Lagovirus, family Caliciviridae)93. 
Virus neutralization tests indicated that all FCV associated with 
“classical” disease isolates are closely related to one another and comprise 
one serotype. Moreover, data from several studies suggested that viruses 
recovered from cats with different clinical signs or from disparate 
geographic regions are similar genetically 67,44,108. The conclusion from 
several genetic studies on the FCV capsid protein also argued for only one 
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FCV genotype 6,44,48,59. In contrast, some data suggest antigenic clustering of 
the isolates associated with similar clinical signs 34.  
The nucleotide homology of the complete genome of different isolates 
ranges between 79.4-80 % 150. Sequence analysis of ORF1 suggests that 
some variable areas exist within this region.48 The nucleotide homology of 
the capsid gene among FCV isolates ranges from 77.1- 81% while the amino 
acid similarities are 88-91%. However, the nucleotide homology is only 55-
75% when the hypervariable areas (E) were compared 23,48,50,132,134,150. The 
nucleotide homology of the ORF3 is 84-86%, while the amino acid 
similarity is 90-95.3% 134,150.  
The genetic relationship of a FCV isolate associated with 
hemorrhagic-like disease with other FCV viruses has been investigated by 
selectively comparing 180 to 210 of approximately 300 nucleotides of the 
hypervariable E region encoding the capsid protein. Researchers concluded 
that the new viruses were closely related to known FCV isolates 130. On the 
basis of this fragmentary sequence data, it is difficult to explain any genetic 
basis for the pathogenesis variability of FCV. Unfortunately a systemic 
comparison of various regions of the genome has never been done to 
conclusively exclude the existence of genetic variants that may be 
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responsible for the newly identified FCV virulent isolates. Changes in 
pathogenicity of the viral diseases have been documented. The pathogenicity 
of some virus isolates has been associated with genetic changes in different 
parts of the genome and different types of mutations. Examples for these 
genomic alterations include insertions of cellular sequences, duplications of 
viral sequences, and genomic  rearrangements in non-structural protein 
(bovine virus diarrhea virus) 141. A large deletion in the 5'-region of the 
transmissible gastro-enteritis virus (TGEV) spike glycoprotein gene may 
have been responsible for a change in tissue tropism from gastrointestinal 
tract to respiratory epithelium 15,121, while point mutation of the capsid 
protein (VP1 and VP2 proteins) of the parvovirus is attributed to the  genetic 
differences between canine parvovirus and feline panleukopenia 60. More 
genetic analysis is needed to determine if the enhanced pathogenicity of 
FCV is due to genetic variation 61,100. 
Researchers working with FCV isolates have focused their work on 
the genetic analysis of the capsid protein gene and its hypervariable region 
(E) while entire genome sequences have been determined only for six FCV 
isolates associated with classical disease. Pathogenicity markers have been 
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mapped to these regions in some other viruses such as bovine viral diarrhea 
(BVDV) 105. 
The purpose of this research was to determine systematically the 
antigenic and the genetic basis which may be responsible for the FCV 
pathogenicity differences. Genetic data from other virus families, such as 
parvovirus, flavivirus and coronavirus in which mutations were considered 
the main reasons for their pathogenicity changes 60,121,141. Genetic differences 
of the FCV associated with hemorrhagic-like disease may be the reason of 
the phenotypic change for FCV pathogenicity. This conclusion leads to my 
hypothesis that differences in the pathogenicity of FCV virus strains are 
genetically and consequently, antigenically determined.  
In this investigation, the complete genome sequence of six FCV 
isolates was determined: two hemorrhagic disease-associated FCV isolates, 
three isolates representing other clinical “classical” diseases (isolated at the 
University of Tennessee, College of Veterinary Medicine, Clinical Virology 
laboratory over the last ten years), and one isolate obtained from National 
Veterinary Service Laboratories, USDA. The sequence data were used to 
determine the genetic relationship of the hemorrhagic disease-associated 
isolates to one another and to the other FCV isolates (including sequence 
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data deposited in GenBank). These analyses could reveal the genetic basis of 
FCV pathogenicity and identify variable and conserved regions of the FCV 
genome that could be exploited for FCV molecular diagnosis and molecular 
epidemiology. Serology on samples obtained from the animals infected with 
the hemorrhagic disease-associated FCV was done to compare antigenic 
relationships to genetic data. 
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II- Literature review 
History and initial isolation 
Feline herpes virus and feline calicivirus (FCV) are the most 
important pathogens involved with feline respiratory disease. Feline herpes 
virus produced inclusion bodies in cell culture while FCV did not 98. 
Fastier from New Zealand isolated a cytopathogenic agent in 1957, 
from primary kitten kidney epithelial cells  40. The isolated virus failed to 
produce obvious clinical signs in experimentally infected kittens; only 
transient anorexia and diarrhea were observed 40. In the same year, in the 
United States, Bolin isolated another virus from a diseased cat 13. It was 
identified as panleucopenia virus. By 1966, these two viruses were 
regrouped with other viruses that produce respiratory diseases in cats 30. The 
first isolation of a virus that did not produce inclusion bodies in cell culture 
from cats with respiratory illness was reported in 1960 28,29. The latter virus 
was isolated from the blood and throat of a sick cat and the disease was 
reproduced when the isolate was administered to a group of cats 29. In the 
same year, investigators reported a group of cytopathogenic viruses which 
had been isolated from cats with respiratory disease 12. Viruses isolated by 
Fastier 40, Bolin 13, Crandell and Madin 28, Crandell et al. 29, and Bittle et al 
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12,  had common biochemical and biophysical properties and were grouped 
as feline picornaviruses 5,27,65. 
Characterization 
Burki was a pioneer in the effort to identify viruses that cause 
respiratory diseases in cats that did not produce inclusion bodies in cell 
culture 16. They were classified as picornaviruses because they contained 
RNA, were resistant to ether and chloroform, and passed through filters of 
50 nm average pore diameter. Burki and Zwillenberg continued the effort to 
identify these viruses using electron microscopy 162. The morphology and 
structure of the capsid differed from other picornaviruses. Calicivirus virion 
had a size of about 40 nm in diameter and had a slightly radiate and 
reticulate appearance. Despite the shape and size differences of these viruses 
from picornaviruses, they were still classified as picornaviruses due to the 
similarities of the model structure. The difference between picornaviruses 
and the viruses causing feline disease were supported by other electron 
microscopy studies 2,14 and physico-chemical characters 103,142. A later study 
presented data indicated that the virus replicates in cytoplasm and is released 
by cell lysis 103. An electron microscopy study showed that the virus lacks an 
outer envelope 140. The classification of these viruses was changed from 
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picornavirus to calicivirus, based on several criteria, summarized in report 
1974 18. 
Clinical diseases 
Feline calicivirus (FCV) is a significant pathogen of cats, producing a 
wide range of clinical diseases, the most important of which is acute upper 
respiratory tract disease 32. Clinical signs associated with infection include 
anorexia, lethargy 28, ocular discharge, nasal discharge 5,28,70,109, lingual 
ulcers 58,70,109, soft palate epithelial necrosis and deep ulceration 158, chronic 
gingivitis, pharyngitis 149, chronic stomatitis 70,146, and pneumonia 58,109. 
Other disease manifestations have been reported and include lameness and 
acute arthritis (limping syndrome), following vaccination and natural 
infections 24,32,101. Virus antigens were demonstrated in various joints of the 
infected cats 32. Jaundice and death in fetuses from in utero FCV infection 
have been reported 9,39,154. Other reports have implicated calicivirus infection 
in urolithiasis and lower urinary tract disease of cats 73,123,124. The presence 
of feline calicivirus particles in the lymphoid tissue (including the tonsils, 
pharyngyeal lymph node and spleen) of infected cats is a constant finding 
57,66,109. 
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Experimental infection studies have been used to confirm the nature 
of clinical disease produced and to determine the pathogenesis of FCV 
infection.  The route of infection played a role on the outcome of infection. 
The intra-nasal route was more efficient in eliciting respiratory tract disease 
than the aerosol route 95. The pathogenicity was relatively constant when 
specific pathogen free cats were infected with a variety of antigenically and 
genetically different FCV strains 95,106,147. Experimental infections have 
revealed the role of FCV in lower respiratory tract infection. Feline 
calicivirus often causes interstitial pneumonia which is characterized by 
diffuse molting due to pulmonary congestion and edema 57,95,109. 
Ultrastructural studies revealed that the FCV has marked tropism for 
alveolar pneumocytes, and induced necrosis of pneumocytes within 12 hours 
of exposure 76. FCV is associated also with acute serofibrinous and 
neutrophilic inflammation in the distal part of the respiratory tract 77. 
A calicivirus-associated with systemic, hemorrhagic-like disease with 
significant mortality has been reported recently 81. The clinical signs of the 
“new” syndrome included severe upper respiratory infection, oral vesicles 
on the margins of the tongue and soft palate and crusty, ulcerative lesions on 
face and pinnae 81. The disease was characterized by diffuse cutaneous 
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edema of the face and submandibular area, over the muzzle, pinnae, and 
lower limbs. The latter signs gave the disease its name “hemorrhagic-like”. 
Experimental inoculation resulted in edema of the face and limbs and 
hyperbilirubinemia of cats 81. Histopathological lesions, of the naturally 
infected cats was subcutaneous edema on the lateral body wall, pinkish 
milky fluid in the pleural cavity and serosanguinous fluid in the abdominal 
cavity with fibrin clots 100. The histopathological lesions associated with   
the same FCV virus in experimentally infected cats, included large areas of 
subcutaneous edema, hepatic necrosis, pancreatitis, intestinal crypt necrosis, 
and acute multifocal interstitial pneumonia 100. Antibodies against the 
vaccine virus did not react significantly with the new isolate 61,100. Other 
outbreaks have been reported throughout the United States 61,115,130. Immuno-
histochemistry detected viral antigen in endothelial and epithelial cells of the 
affected tissues 102. This disease is similar to rabbit hemorrhagic disease 
caused by another calicivirus (genus Lagovirus, family Caliciviridae) 93. 
Existence of a FCV carrier state in cats is not uncommon 157,159. Cats, 
after recovery from the acute phase of primary infection with FCV, become 
persistently infected and shed the virus from the oro-pharynx for a prolonged 
period (more than 2.5 years) despite having a high titer of neutralizing 
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antibodies 112,156. The tonsillar region (including the surface epithelium of 
the tonsil, and adjacent fossa mucosa) is considered the primary organ of 
persistence in asymptomatic carriers 36,112,158,158. Kittens from queens 
persistently infected with FCV usually get mild or sub-clinical infection 64. 
Isolation rates of FCV from cats with chronic stomatitis (up to 92%) are 
higher than the isolation rates of FCV from clinically healthy cats (from 7.3- 
43%) 26,69,149,157,159. 
A number of viral agents, including FCV, feline-immunodeficiency 
virus, feline herpes virus type 1 and feline leukemia virus, are involved in 
causing chronic oral infection in cats 146. Feline calicivirus, solely or in 
association with other viral agents, is considered one of the most frequent 
pathogens involved in chronic oral infection of cats 69,146. Experimental 
infection, with virus isolated from cats with chronic stomatitis, failed to 
induce chronic infection 149. 
Epidemiology 
Feline calicivirus infection is  widespread and has worldwide 
distribution. FCV was first described in New Zealand, and subsequently in 
many other countries 7,16,29,40,144,161. The isolation rate of FCV from domestic 
cats was around 20% and suggested that younger cats are more susceptible 
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to infection than older cats (more than one year of age) 19,51,110. The isolation 
rate was higher (26-31%) from cats in a rescue shelter 118. 
Feline calicivirus has been isolated from other felidae including 
captive cheetahs 127. Experimental infection of domestic cats with the virus, 
isolated from cheetah, produced classical clinical disease. The clinical signs 
included pneumonia, ulcerative glossitis, conjunctivitis and anorexia 80. The 
antibody prevalence of FCV was 65% in free-ranging Namibian cheetahs 89, 
26% in wild cats from Scotland 31, 33.3% in wild cats from Taiwan and 
Vietnam 62 and 40% in wild cats from Saudi Arabia 97. 
Prevalence of antibodies against FCV was reported for many other 
free-ranging animal species around the world.  Antibodies against FCV were 
detected in 70% of sera from free-ranging lions in East Africa (Tanzania’s 
national park) (with different rates of samples from different locations) 55, 
17%  sera from free-ranging mountain lion in the United States 99 and 56% 
in the sera of free-ranging Florida panthers 126. The antibody prevalence was 
72% in spotted hyenas in the Serengeti ecosystem in Tanzania, Africa 52. 
Taxonomy and viral properties 
Caliciviridae has four genera; Vesivirus (swine vesicular exanthema 
virus, feline calicivirus, and others), Lagovirus (Rabbit hemorrhagic disease 
 13 
virus), Norovirus (Norwalk virus) and Sappovirus (Sapporo virus). Vesivirus 
obtained its name from the prominent vesicles that characterize the clinical 
diseases 148. Calicivirus particles have cup-shaped depressions on the virion 
(figure 2.1) visible by negative stain electron microscopy (Calyx; Latin for 
cup or chalice) 25. The virus particles have a diameter of about 40 nm with 
32 cup-shaped surface structures, each comprising 90 arch-like capsomeres, 
arranged in icosahedral symmetry 25. The acid sensitivity of feline 
caliciviruses varies from one isolate to another 79. 
The organization of the caliciviruses genome is different according to 
the genus; figure 2.2 shows the different genera and their genome 
organization. The FCV genome consists of a single-stranded RNA 1,38,81. It 
has a poly-adenyl tail at the 3` end 38, and has positive polarity. The genome 
contains 7678 to 7693 nucleotides and encodes three open reading frames. A 
characteristic feature of FCV genome organization is a 5` non-structural 
polyprotein preceding the structural capsid protein. The 3` end of the 
genome has a small ORF which encodes a structural protein with unknown 
function (figure 2.2) 22,48,96. In calicivirus-infected cells, two kinds of viral 
specific RNA are transcribed; genomic RNA and 2.4 kb subgenomic RNA. 





               
 
 


























Figure 2.3: the position of sub-genomic RNA of the FCV 148 
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ORF1 is 5308 nucleotides long (nucleotides 20 to 5305) encoding 1763 
amino acids. It encodes a large polyprotein, which undergoes co-
translational cleavage yielding six nonstructural proteins ranging in size 
from 5.6 kd to 75.6 kd. They are p5.6, p32, p39 (NTPase), p30, p13 (VPg), 
and p76 (proteinase-polymerase) (figure 2.4) 20,20,71,136,136,139,160. The p76 
(proteinase-polymerase) is similar to picornavirus 3C proteinase and 3D 
polymerase domain 139. A 3C-like cysteine proteinase is responsible for co-
translational proteolytic processing of ORF-1 and the capsid protein 
precursor 138,139. The full-length proteinase-polymerase protein is the active 
form of RNA-dependent RNA polymerase 160.  
The cleavage site between p5.6 and (p32) is E46/A47. The other 
cleavage sites are: E331/D332 between p32 and p39 (NTPase), E685/N686 
between p39 and p30, E960/A961 between p30 and p13 (VPg) and E1071/S1072 
between p13 VPg and pro-pol 136,139. 
The ORF2 has approximately 2004 nucleotides (nucleotide 5314 to 
7317-7326). It encodes the capsid protein and is predicted to have about 668 
amino acids, the putative 76 kd capsid precursor protein 20,23,92,152. The latter 
is subsequently cleaved by a viral-encoded proteinase, resulting in a 65-66 









Figure 2.4: A) the organization of the three ORF of FCV, B) different 





When the genetic bases encoding the mature form were cloned and 
then expressed in cell culture, the product was a virus-like particle 
resembling the FCV mature virion 42,43. 
The capsid protein gene is divided into six areas based on genetic 
variability, and designated A, B, C, D, E, and F representing amino acids 
residues 1-120, 121-396, 397-401, 402-425, 426-520 and 521-668 
respectively of the ORF2 90,133. Area E, identified as a hypervariable region 
of the capsid protein, is probably responsible for the feline calicivirus 
antigenic variations 6,44,48,90,133,134. 
ORF3 contains 318 nucleotides and encodes a 106 amino acid 
protein. The start codon for ORF3 overlaps the stop codon of ORF2.  It is a 
minor structural protein, VP2, with an unknown function and is found in 
small amounts relative to the major capsid protein 54,92,137,152. VP2 has a 
calculated molecular weight of 12.5kd but it behaves like an 8.5 kd in 
polyacrylamide gel electrophoresis (PAGE) that may be attributed to an 
unusual mobility in SDS-PAGE 137.  
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The nucleotide homology of the complete genome sequences 
available from Genbank for six isolates associated with classical form of the 
disease ranges between 79.4-80 % 49,150. Sequence analysis of ORF1 of these 
isolates suggested that some variable areas exist within this region.48 The 
nucleotide homology of ORF1, the non-structural polyprotein, for these 
isolates, ranged from 77.8-80.7%, while deduced amino acid similarities 
ranged from 90-95.5% 48,96,150. The nucleotide homology of the capsid gene 
among FCV isolates ranged from 77.1- 81% while the amino acid 
similarities were 88-91%. However, the nucleotide homology was only 55-
75% when the hypervariable areas (E) were compared 6,23,48,50,132,134,150 49,85. 
The nucleotide homology of the ORF3 among FCV isolates was 84-86%, 
while the amino acid similarity was 90-95.3% 85,134,150. Genetic studies on 
the FCV capsid protein also suggested that only one genotype of FCV exists 
6,44,48,59. However, other genetic data suggest antigenic clustering of the 
isolates producing similar clinical signs 34,83.  
The genetic and antigenic relationship among FCV isolates 
The relationship among FCV isolates, associated with different 
clinical diseases and different geographical location, has been studied 
extensively. Analyses have included serological assay, plaque morphology 
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and some genetic analyses 67.94 Virus neutralization patterns 17,34,67,68,78, 
immuno-diffusion 67, and an ELISA assay 83 have been used to study the 
relationship among different FCV isolates. These studies suggested that 
FCV isolates were closely related to one another and comprised one 
serotype. In addition, genetic diversity was not noted among viruses 
recovered from cats with different clinical signs or from disparate 
geographic regions. The phylogenetic analysis has been used to study the 
genetic relationship among different genera of caliciviruses 10. It has been 
used also to analyze the relationship of FCV field stains among one another 
and their relationship to vaccine strains 10,114,128. The capacity of the genetic 
studies to segregate virus strains has been compared to the antigenic analysis 
(virus neutralization) 117. Virus neutralization data suggested that wide 
spectrum of antigenic variations existed among FCV isolates and in contrast 
the genetic analysis suggested that FCV isolates have a close relationship to 
one another 117. 
Genetic studies on the genomic domain encoding the FCV capsid 
protein also suggest that only one genotype of FCV exists 6,44,48,59. However, 
some data suggest antigenic clustering together of isolates producing similar 
clinical signs 34,83. By using the neutralization cross reactivity, FCV isolated 
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from the same geographical area did not segregate together 68. In contrast, 
phylogenetic analysis using the capsid gene sequence data, segregated 67% 
of the Japanese FCV isolates together (geographical segregation) 128. Most 
of the genetic analyses of FCV have targeted the hypervariable area (E) 
114,116,128. It is considered the immuno-dominant region of the capsid gene 
114,116,128.  The nucleotide distance, by sequencing the E area of the capsid 
protein gene, ranged between 0-16% for isolates  from the same cat colony 
or for epidemiologically-related viruses, while it ranged between 20-40% for 
unrelated isolates 114,116.  
The genetic relationship of a FCV isolate associated with 
hemorrhagic-like disease with other FCV viruses has been investigated by 
comparing nucleotide sequences of the hypervariable E region of the capsid 
protein gene. Researchers concluded that the new viruses are closely related 
to known FCV isolates 61,100,130. The capsid protein gene was sequenced to 
determine the genetic relationship between the FCVs causing lower urinary 
tract disease to vaccine and other field FCV isolates 123.  Two FCV isolates 
associated with lower urinary tract disease had no relationship to one another 
123. 
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Cross-neutralization tests revealed that FCV undergoes antigenic 
changes over the course of persistent infection in cats 63,72,119. On the other 
hand, the frequent passages of FCV in cell culture did not result in antigenic 
changes measured by neutralization activities when the early passages of the 
viruses were compared to late passages of the virus 119. Western blot analysis 
using polyclonal antibodies against the parent virus with putative progeny 
viruses from the persistently infected cats indicated antigenic homogeneity 
among all FCV isolates. In contrast, analysis of the hypervariable region of 
these isolates revealed changes affecting encoded amino acids 72. 
Vaccination and immune response 
Licensed modified-life and inactivated vaccine for FCV are available 
41,111,131. Furthermore, an experimental recombinant capsid protein vaccine 
elicited high antibody yields when administrated to cats 84. A DNA vaccine 
using a plasmid encoding the mature capsid protein did not protect cats 
against clinical disease ,135. Despite widespread vaccination, FCV-associated 
disease is still a significant clinical problem. Vaccination only protects 
against clinical disease and sub-clinical and persistent infections still occur 
32,5133,107. Neutralizing antibodies, from cat sera, produced against various 
vaccine strains only cross-reacted with 22 to 70% of the FCV field isolates 
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56. FCV strain F9 was the most used in vaccine preparations because it 
elicited antibodies with a higher degree of cross-neutralization against other 
FCV isolates 11,67.  
The neutralizing antibody epitopes of FCV were mapped to the 5’ end 
of the hypervariable E area of the capsid protein gene 45,88,120,151,153. Milton et 
al identified that this area contains amino acid residues 422 to 458 of the 
capsid protein and was capable of binding to two kinds of neutralizing 
antibodies 88. Tohya located two neutralizing epitopes in the region at amino 
acid residues 426 to 460 and 490 to 520 153.  Non-neutralizing antibody 
epitopes were mapped to areas B, C, D and F of the capsid protein 45,88. The 
antibodies induced in experimentally immunized mice with recombinant 
capsid protein, cross-reacted with homologous and heterologous FCV 
isolates by Western blot which suggested that these epitopes are localized 
within the conserved areas of the capsid protein 44,45,88. 
Diagnosis of infection 
Diagnosis of FCV is based mainly on virus isolation in cell culture 
followed by serological identification by immunofluorescence 46. 
Immunohistochemistry in tissue from cats in the acute phase of disease 
efficiently detects FCV in formalin-fixed tissue 35. Development of 
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diagnostic nucleic acid amplification techniques has been investigated. 
Reverse-transcription PCR (RT-PCR) has been developed using a primer set 
targeting a 670-680 base pair segment of the capsid protein gene 68,143. A 
nested RT-PCR was more sensitive than a one step procedure 82. A real-time 
PCR for FCV detection has been developed using SYBR Green instead the 
specific molecular probe 53,129.  
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III- Material and methods 
 
Experimental design: Two FCV isolates causing the hemorrhagic-like 
disease were compared by genetic and antigenic analysis to four isolates 
associated with classical diseases and to one another. The entire genomes of 
these six FCV isolates were sequenced, by direct amplification of targeted 
irrelevant areas of the genomes, using RT-PCR followed by determination of 
the base sequences. The genetic relationships among the different isolates 
were determined using phylogenetic analysis and degree of similarities, 
using nucleotide sequences and deduced amino acid sequences, among 
different FCV isolates. These relationships were studied for each part of the 
genome including structural, non-structural proteins genes and untranslated 
5’ and 3’ areas. The antigenic differences among these isolates were 
determined by cross neutralization and immuno-fluorescence. 
Viruses: Six FCV isolates were included in the study. Five had been isolated 
at the Clinical Virology Laboratory, College of Veterinary Medicine, 
University of Tennessee over the last 10 years. Two of these isolates had 
been associated with hemorrhagic disease, designated UTCVM-H1 and 
UTCVM-H2 (University of Tennessee, College of Veterinary Medicine-
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Hemorrhagic), three had been associated with classical signs of FCV, 
designated UTCVM-NH1, UTCVM-NH2, and UTCVM-NH3 (University of 
Tennessee, College of Veterinary Medicine-Non-Hemorrhagic), and one 
isolate was obtained from National Veterinary Service Laboratories, USDA. 
UTCVM-H1 isolate was identified as one associated with hemorrhagic 
disease based on the clinical signs and diffuse vasculitis found on necropsy 
(table 3.1). UTCVM-H2 isolate was identified as one associated with 
hemorrhagic disease based primarily on clinical signs described for the 
syndrome.130 Laboratory tests supported the diagnosis and ruled out other 
etiologies (including FIV, FeLV, Ehrlichia canis, Ehrlichia chaffeensis, 
Rickettsia rickettsii, aerobic and anaerobic bacteremia, and Blastomyces 
dermatitidis). FCV was isolated from lung (H1) and oral swab (H2).  Table 
3.1 shows the clinical signs, date of isolation, geographical location of the 
infected case(s) and the necropsy findings (if available) for each FCV 
disease occurrence. Genome sequence data of six other FCV isolates were 
obtained from the GenBank (names and accession numbers are given in the 
results section), and used for genetic analysis. Partial sequence data (180-
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Table 3.1: feline calicivirus isolates used in this study 






Case history and clinical signs Necropsy finding (if available) 




Depression, high fever, oral and lingual 
ulceration. Two other cats in the house 
hold  died with similar signs 
Not Done 
UTCVM -NH2 1998 Kentucky  Nasal swab Eye lesion and upper respiratory signs Cat survived 
UTCVM -NH3 2000 Tennessee Lung, 
nostril, 
tissue 
six years old, female Ragdoll cat 
suffered from: moderate ventral 
subcutaneous edema, fever, vomiting, 
and nasal discharge. Died within 24 
hours. 
Nasal turbinate mildly edematous, patchy 
necrosis of alveolar epithelium, alveolar 
edema, moderate to severe, acute, locally 
extensive, suppurative bronchointerstitial 
pneumonia. 
UTCVM -H1 1999 Tennessee Lung Outbreak affected eleven cats. 
Pneumonia and vasculitis, with three 
deaths. The virus was easily transmitted 
and rapidly spread to other cats in the 
facility. Clinical signs were high fever, 
depression, anorexia, jaundice, and 
necrotic lesions of the pinnae.  Blood 
work evidenced thrombocytopenia, 
bilirubinemia, leukopenia to 
leukocytosis, and elevated liver 
enzymes 
Necropsy was done on two cats. The 
lung was markedly hemorrhagic with 
serosanguinous fluid on section, micro-
vascular thrombosis, marked endothelial 
hyperplasia, intra alveolar hemorrhage 
with fibrin, marked vascular congestion 
and mild to moderate, diffuse pulmonary 
edema was observed. Kidney had 
hemorrhage at corticomedullary junction. 
Pinnae had sub-epidermal vesicle 
formation mild multifocal microvascular 
thrombosis  
UTCVM -H2 2002 Tennessee Oro-
pharyngeal 
swab 
Five year old male; Lameness, swollen, 
edematous limbs and joints, ventral 
abdominal edema, anorexia, fever, oral 
ulcer. Ulceration on mandibular lip. 
Ehrlichia canis, FELV/FIV, 
Blastomysis testing were negatives. 
cat survived 
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210 nucleotides) of three FCV isolates associated with hemorrhagic disease 
in cats were obtained from published articles (FCV-Ari,100 FCV-cat 15,130 
FCV-kaos 61). 
Serum samples: Five convalescent serum samples from cats infected with 
the UTCVM-H1, a serum sample from the cat infected with UTCVM-H2 
and a negative control serum (obtained from Liberty Research a) were used 
in this study to detect the neutralization titer and for the cross-neutralization 
test. Eleven convalescent sera (including the five sera for virus 
neutralization) from the outbreak caused by UTCVM-H1 were examined by 
immuno-fluorescence to detect the antibody response against the FCV 
infection. 
Virus propagation: Crandell-Reese feline kidney (CRFK) cells were used 
for virus isolation and serum virus neutralization assays. The CRFK cells 
were grown with Dulbecco’s Modified Eagle Medium (DMEM) b 
supplemented with 5% heat-inactivated fetal bovine serum with standard 
concentrations of penicillin, streptomycin and amphotericin. After samples 
preparation (given in table 3.1), confluent monolayer of CRFK cells, grown 
in 75 cm2 flask, were inoculated and observed daily for cytopathic effect 
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(CPE). The viruses were grown until 50-70% CPE developed and the cells 
were collected for RNA extraction. 
Negative staining electron microscopy:  the primary diagnosis was done 
using direct immuno-fluorescence and electron microscopy. Two of 75 cm2 
flask CRFK cells were used to grow the virus. The infected cells were 
collected along with the medium and then centrifuged at 14,000xg at 4 °C 
for 50 minutes. The supernatant was discarded and the pellet re-suspended in 
double distilled water and then centrifuged again. 100 ul from 3% PTA 
(phosphotungstic acid) was mixed with 100 ul of the cell suspension and 
mixed. Electron microscopy grids were sprayed 5-10 times and then 
examined. The FCV particles were detected by electron microscopy. 
RNA extraction: RNA was extracted with Trizol LS reagent c according to 
the manufacturer’s protocol. In brief, the infected cells were collected from 
the 75 cm2 flask, and then pelleted using low speed centrifugation (1000 x g) 
for 5 minutes. The cell pellet was resuspended in 750 ul Trizol reagent, and 
incubated for five minutes at room temperature. Two hundred µl chloroform 
was added to the suspension, incubated for 2-3 minutes at room temperature, 
and then centrifuged at 12,000 x g for 15 minutes at 4°C. The RNA, the 
aqueous upper phase, was precipitated by adding 500 µl isopropyl alcohol; 
 31 
the mixture was incubated for 10 minutes at room temperature and then 
centrifuged at 12,000 x g for another 10 minutes at 4°C. The pellet obtained 
after centrifugation was washed with one ml 75% ethyl alcohol and then 
centrifuged at 7500 x g for five minutes at 4 °C to obtain the RNA pellet. 
The RNA pellet was air dried and dissolved in 100 µl Rnase-free water.  
Primer design: For RT/PCR, the FCV genome was divided arbitrarily into 
three major and three minor segments (Figure 3.1). Two primers (5 and 6) 
have been used before 1. Various primer pairs used for RT-PCR 
amplification (Table 3.2) were based on published sequences; the most 
conserved areas of the genome were chosen. Additional sequencing primers 
were derived from the generated sequence data. 
cDNA synthesis: Synthesis of cDNA was done using M-MLV Reverse 
Transcriptase c according to the manufacturer’s protocol. In brief, 1 µl of the 
antisense primer (50µm), 4 µl from 10mM dNTP mix, and 1-4 ng of total 
RNA were mixed and made up to 12 µl with Rnase-free water. The mixture 
then was heated to 65°C for 5 minutes and quick-chilled on ice. Following 
this, 4 µl 5x first-strand buffers, 2 µl 0.1 M DTT and 1 µl RnaseOUT 
recombinant ribonuclease inhibitor (40units) c, were added and the mixture 












PCR#1, 2-7kb     
primer 1               primer 2 
    ?       ?  
nt 1-21   nt 2769-2787 
 
PCR#2, 2-5 kb    
primer 3                 primer 4 
 ?                   ?  
nt 2769-2787       nt 5325-5345 
 
PCR#3, 2.2 kb     
    primer 5     primer 6 
nt 5286-5307 nt 7547-7567 
   ?                        ?  
 
PCR#4, 0.8 kb    
primer 7         primer 8 
    ?                   ?  
nt 2417-2436 nt 3266-3285 
Figure 3.1: the genomic segments amplified by RT/PCR and the 
corresponding primers for each: nucleotides numbers indicate position in the 
genome. 
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Table 3.2: primer sequences used for RT, PCR reaction and sequencing 
Primer  Primer sequence 
Primer 1 5`-GTAAAAGAAATTTGAGACAAT-3` 
Primer 2 5`-ATTTCAGACCATGGCATTG-3` 
Primer 3 5`-CAATGCCATGGTCTGAAAT-3` 
Primer 4 5`-TATTTAAGCACGTTAGCGCAG-3` 
Primer 5 5`-TACACTGTGATGTGTTCGAAGT -3` 
Primer 6 5`-GTGTATGAGTAAGGGTCAACC-3` 
Primer 7 5`-GATGAACTACCCGCCAATCA-3` 
Primer 8 5`-ACATCAGTGACTGATCCAAT-3` 
Primer 9 5`-TAACTRGCACAAGAAGGR(A+G)CA-3` 
Primer 10 5`-TGAGTCGATGACTCTAGCTTTTTTTTTTTTTTTTTT3` 
Primer11 5`-TGAGTCGATGACTCTAGC-3` 




was added, the mixture was incubated for 50 minutes at 37°C, and then 
heated at 70°C for 15 minutes to inactivate the enzymes. 
Polymerase chain reaction (PCR); According to the manufacturer’s 
protocol d, 10 µl of 10X Ex Taq buffer, 8 µl dNTP mixture (2.5 mM each), 1 
µl of the sense primer (50um), 1 µl of the antisense primer (50µm), 0.5 µl 
TaKaRa Ex Taq (5 units/µl), 4 µl of the cDNA were combined, and made up 
to 100 µl with Rnase-free water. The mixture was reacted in a thermal cycler 
e initiated by denaturation at 95°C for 1.5 minutes, followed by 30, three-
step cycles consisting of annealing at 58°C for 30 seconds, extension at 72°C 
for one minute and denaturation at 95°C for one minute. At the end of the 
last cycle, the reaction was held for 2 minutes at 50°C followed by 5 minutes 
at 72°C. 
Genetic sequencing: The PCR products were purified by gel extraction. The 
products were electrophoresed in 1% agarose f gel in 1X TBE buffer. The 
band representing the expected size was purified from the gel using 
MinElute Gel Extraction kit and done according to the manufacturer’s 
protocol g in a microcentrifuge. The gels, with the DNA fragment was 
excised with a clean, sharp scalpel and placed in a colorless tube, and 
weighed. Three volumes of buffer QG to one volume of gel weight were 
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added. The mixture was incubated at 50°C with frequent vortexing, for 10 
minutes (or until the gel slices has completely dissolved). After complete 
dissolving of the gel, the color was checked to see if it was still yellow. One 
gel volume of isopropanol was added to the mixture and the tube was mixed 
by inverting it several times. The mixture was placed to a MinElute column 
in a 2 ml collection tube and centrifuged for 1 minute. The flow-through was 
discarded and 500 µl QG buffer was added to the column, centrifuged for 1 
minute, and the flow-through was discarded. The MinElute column was 
washed with 750 µl of PE buffer and incubated for 5 minutes, centrifuged 
for 1 minute and the flow-through was discarded. Residual PE buffer was 
removed from the MinElute column by centrifugation for an additional 1 
minute at maximum speed of the micro-centrifuge (~16,000g). The 
MinElute column was transferred into a clean 1.5 ml microcentrifuge tube, 
25 µl of DNase and RNase free water was added and incubated for 1 minute. 
DNA was eluted from the column by centrifugation for 1 minute; DNA was 
kept at -20°C. Sequencing of the purified PCR products was done at the 
Molecular Biology Resources Service (University of Tennessee, Knoxville, 
TN) h.  
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RACE (Rapid Amplification of cDNA Ends): The 3’ and 5’ ends of the 
FCV genome were determined using the RACE system. The 20 nucleotides 
at the 5’ end were detected using the RACE system kit d and was done 
according the manufacturer’s protocol using primer nine as anti-sense primer 
for cDNA synthesis as well as for PCR (table 3.2). The RACE system used 
for the 3’ end, exploited primer ten, for cDNA synthesis (table 3.2). 
Polymerase chain reaction was done using primer 11 and primer 12, 
targeting about 437-446 bases of the genome representing nucleotides 7244-
7681 (table 3.2) 
Sequence analysis: Determination of ORFs, amino acid sequence, 
alignment, phylogenetic tree construction and nucleotide sequences analysis 
was done using the Wisconsin GCG package. Phylogenetic tree construction was 
performed using distances (neighbor-joining) and growtree programs available in the 
Wisconsin GCG package. 
Virus titration: 200 CCID50 was used in virus neutralization tests. The virus 
stock of each FCV isolate was aliquoted and kept at -70°C. The procedure 
for virus titration was done according to the following protocol: the viruses 
were titrated in CRFK cells were in 96 wells plates. Seeded with 100 µl of 
1.0x10-5 cells/ml suspension, and then incubated at 37°C in the CO2 
incubator. Ten-fold serial dilutions through 10-10 of the virus stock in 
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DMEM with 2% fetal bovine serum was prepared. After the cells became 
confluent, 100 µl of each virus dilution was placed in each of five wells. 
Starting with the 10-10 dilution, the plates were incubated at 37°C in 5% CO2 
four days. The plates were monitored for CPE. The CCID50 was calculated 
using Reed and Munch formula 122.   
Virus neutralizing antibody assay: Convalescent serum samples were 
tested for neutralizing antibodies against four of the six FCV strains used in 
this study (UTCVM-H1, UTCVM-H2, UTCVM-NH1 and USDA). The 
serum samples were heated at 56°C for 30 minutes. Two-fold serial dilutions 
of a 1:5 through 1:2560 dilutions were done in disposable sterile test tubes in 
DMEM supplemented with 5% fetal bovine serum, and starting with 1: 5 
dilution. 25 µl of each dilution was transferred into 96-well microtiter plates. 
Then 200 CCID 50 of a FCV isolate in 25ul medium was added to each well. 
The reaction was incubated at 37°C for 45 minutes, and then 50 µl of 2 x 10 
5 cells/ ml cell suspension was added to each well. These procedures were 
done in duplicate. The back titration of each FCV was done to verify the 
virus titer. The plates were incubated for three days at 37°C and examined 
under an inverted microscope for typical FCV CPE. The reciprocal of the 
highest serum dilution without detectable CPE was read as the endpoint. 
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Serum titration by indirect fluorescent antibody test: Four different types 
of FCV antigen placed on slides representing different types of FCV isolates 
were used. They were: slide coated with UTCVM-H1, USDA and two types 
of slide obtained from Fort Dodge vaccine company j (type C is a field 
unknown strain and type D is the vaccine strain F9). Two-fold serial 
dilutions of the convalescent sera in PBS were made (1:40 through 1:10560). 
The dilutions were added to the wells, including monoclonal antibodies 
positive control and a negative control, and then incubated for 30 minute at 
37°C. Three washes in PBS for 5 minutes each were made. FITC-labeled 
goat anti-cat IgG k was added to each well; the slide was incubated for 30 
minutes, and then washed three times in PBS. The slides then were 
examined using a fluorescence microscope l and the titer was determined as 





The nucleotide sequences and deduced amino acid sequences of 
isolates UTCVM-NH1, UTCVM-NH2, UTCVM-NH3, UTCVM-H1, 
UTCVM-H2, and USDA, were determined and analyzed. All of the 
sequence data has been sent to GenBank (GenBank information in table 4.1). 
The 5’ untranslated region (UTR) consisted of 19 nucleotides and was 
completely conserved among the sequence of both FCV isolates used in this 
study and the FCV isolates sequence data obtained from GenBank (figure 
4.1). 
The first 56 nucleotides, including the 19 nucleotides of UTR, of the 
genome were completely conserved in all FCV isolates except UTCVM-H1, 
which differed in nucleotides 51 and 52 (figure 4.1) resulting in a 
hydrophilic amino acid {asparagines (N)} replacing a neutral amino acid 
{threonine (T)} (figure 4.2). The change was in residue number 11 of the 
ORF1. 
All of the FCV isolate genomes contained three potential ORFs: 
ORF1 encodes large polyprotein (non-structural proteins), ORF2 encodes 
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Table 4.1: FCV isolates with GenBank accession number and size of 










AY560113 1-19 20-5308 5314-7317 7317-7634 7683 
UTCVM-
NH2 
AY560114 1-19 20-5308 5314-7326 7326-7643 7690 
UTCVM-
NH3 
AY560115 1-19 20-5308 5314-7317 7317-7634 7693 
UTCVM-
H1 
AY560116 1-19 20-5308 5314-7317 7317-7634 7685 
UTCVM-
H2 
AY560117 1-19 20-5305 5311-7314 7314-7631 7678 
USDA 
 
AY560118 1-19 20-5308 5314-7317 7317-7634 7681 
F9 
 
M86379 1-19 20-5308 5314-7326 7326-7643 7690 
F4 
 
D31836 1-19 20-5308 5314-7317 7317-7634 7681 
F65 
 
AF109465 1-19 20-5308 5314-7317 7317-7634 7681 
FCV2024 
 
AF479590 1-19 20-5308 5314-7317 7317-7634 7681 
CFI/68 
 
U13992 1-19 20-5305 5311-7314 7314-7631 7678 
Urbana 
 




                         .         .         .         .         .         .         .       
UTCVM-NH1    1  ---------------------------------------------------------------C------   70 
UTCVM-NH3    1  ---------------------------------------------------------T------------   70 
USDA         1  --------------------------------------------------------A------T------   70 
UTCVM-H1     1  --------------------------------------------------AC-----T-----T------   70 
UTCVM-H2     1  ---------------------------------------------------------------T------   70 
UTCVM-NH2    1  GTAAAAGAAATTTGAGACAATGTCTCAAACTCTGAGCTTCGTGCTTAAAACTCACAGCGTCCGAAAGGAC   70 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1   71  -----------C-----------C---------------------------C--T------GA---AGC-   140 
UTCVM-NH3   71  -----------C---------------------------------------C--TTA----GA---AGT-   140 
USDA        71  -----------C-----------------T---------------------T-CT-------------T-   140 
UTCVM-H1    71  -------T---C------CG---G-----T---------------------T-CT------G--------   140 
UTCVM-H2    71  -----------C-----------------T---------------------T-CT----------A----   140 
UTCVM-NH2   71  TTTGTGCACTCTGTCAAGTTAACACTTGCACGGAGGCGCGATCTTCAGTATATTCATAACAAGCTCTCAC   140 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1  141  --T----G--C--------C--T-----------------T--------------------T---A--A-   210 
UTCVM-NH3  141  A-GT---G-----------C--T--------------------------------------T--CAACAC   210 
USDA       141  ----C--G-----G--------T-----------------T-----C--------------A---ACC--   210 
UTCVM-H1   141  --T--T-G----TA--A-----T-----------C-----T---A-T--------------A---A----   210 
UTCVM-H2   141  ----A--G-----G--------T-----------------T---ACT--------------A---AA---   210 
UTCVM-NH2  141  GCACTATACGTGCTGAGGCTTGCCCTTCTTGTGCTAGTTACGACGTATGTCCTAACTGCACCTCTGGTGA   210 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1  211  -A-T--C--------G--A-------C---------C--T-----------T--G--AA----T--T---   280 
UTCVM-NH3  211  TA-T--T--------G--A-------C------A-----T-----A-----TGTG--AA-C--T--T--T   280 
USDA       211  -A----C-----------G--A-TT-AA-----------G-----------T----GAA----T--T---   280 
UTCVM-H1   211  ---T--T--------G--A-------C------------T--------C--------AA-C--T-----T   280 
UTCVM-H2   211  TA-T--C--C--C--T--G--A-T--AT--------G--C-----A-----------AA-C--T------   280 
UTCVM-NH2  211  CGTCCCGGATGATGGATCTTCGACAATGTCGATTCCATCATGGGAGGATGTCACAAAGTCTTCAACCTAC   280 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1  281  --------G-----C--A--------T--G--AC-C--------C---C---C------T-----C----   350 
UTCVM-NH3  281  --C--T-----------A------A-------AC-T--------T-----------C--T--C-----C-   350 
USDA       281  ------T-G--T-----------T--T-----A--G--------T---C----C--C--T--------C-   350 
UTCVM-H1   281  --------G-----------T-----T--T---C-G--T--CACT--T--A--C-----T-----C----   350 
UTCVM-H2   281  -----T--GT-G--C-----T--T--T--T--AC-TGA-T--ACT---C-------CA-T---T-C--C-   350 
UTCVM-NH2  281  TCTCTCCTACTCTCTGAGGACACCTCCGACGAGTTATGCCCTGAGGACTTGGTTAATGTGGCTGCTCATA   350 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1  351  -T--C--A---T-G-----------G--------C--CAT---------------------------TC-   420 
UTCVM-NH3  351  ----C-----A-----TT-------G-----------CAA---G--------------------C--G--   420 
USDA       351  -T--C------------G----------------A---ATC--C--------------------G--G--   420 
UTCVM-H1   351  ----------A-----TG-C-----A-----A--C----T---G--------------A--------A--   420 
UTCVM-H2   351  ----A-----A--------------T--------A--CAT---C-----T--G--------A--A--G--   420 
UTCVM-NH2  351  TCCGTAAGGCGCTATCCACTCAGTCCCACCCGGCTAATGCTGAAATGTGCAAAGAACAGCTCACTTCCTT   420 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  421  G------G----------A-----A--A--G-----A--GT-AA--C----T--T--T--G------GTA   490 
UTCVM-NH3  421  G--G--T------------------------A----T--GT-AA-TC-T-----T-----G-G---TGTA   490 
USDA       421  GC-G--A--------A--T--------A--G--------GT-AG-GC-G-----T--T--G-------A-   490 
UTCVM-H1   421  G--G--A--------------------------------G--AA--C-----T-----G-T--GT---AA   490 
UTCVM-H2   421  -C-G--TG----C-----T-----A-----------TA--T-A--------T--------------TCAA   490 
UTCVM-NH2  421  ATTAGTCATGGCTGAGGCGATGCTGCCCCAACGATCCCGAGCGTCAATCCCACTGCACCAACAACACACG   490 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  491  A----T--TC----------A--A--G--T-----A-----C--G--T--C--AT-G------A----C-   560 
UTCVM-NH3  491  A-G--T--A---------C-T--A--------------G--A--G--------T-----G---C----C-   560 
USDA       491  --G--T--A---------------------------------T-G--T-----TT-G-----GA------   560 
UTCVM-H1   491  A-A--C--TC-T--G-----A--------------------A--------C--AT-A----AGA----G-   560 
UTCVM-H2   491  A-G--C--AA-T--------A--A--G-----T-----G--AT-G--T--C--T---------A------   560 
UTCVM-NH2  491  GCTGCGCGGTTGGAATGGAGGGAGAAATTCTTCTCTAAACCTCTTGACTTTCTCCTTGAAAGAGTTGGTG   560 
                                                                                     
                         .         .         .         .         .         .         .       
UTCVM-NH1  561  CC---------G----T----TC--G--C-----------C--T--------G--T--------------   630 
UTCVM-NH3  561  -------G--------T----T---AT-A--C--------------------G--T-----C--T-----   630 
USDA       561  -------G-----A--T-----A--C--A-----------C---C-A--G--------------------   630 
UTCVM-H1   561  CA--T-----C--C--T----TC-----T------------G-TC-T-----G--T-----C-----A--   630 
UTCVM-H2   561  ----C-----------A--GGT------C--------G---C-------G-----------C-----A--   630 
UTCVM-NH2  561  TGTCAAAAGATATTCTCCAAACTACTGCGATTTGGAAAATTATCTTGGAAAAAGCATGCTATTGCAAGTC   630 
  
Figure 4.1: the nucleotide sequences of the complete genome for the six isolates of 
FCV used in this study. The sequence for UTCVM-NH2 isolate is shown; for the 
other isolates, only nucleotides that differ from UTCVM-NH2 are shown. The dots 
above the sequences are spaced every 10 residues 
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                         .         .         .         .         .         .         .      
UTCVM-NH1  631  ------G--AG-------T-A------A--AAG----A-TG-A--G--C-----T------TACTCA--C   700 
UTCVM-NH3  631  T--C--T--AG-C-------A--TG-----A-----A--G--T-T-G-A-GC--AA-------CTCC--A   700 
USDA       631  A-----T-----A-----TGAC--G--A--A--------G--------A----GT-----AG-CA-C--A   700 
UTCVM-H1   631  A--C--T--AG-A-------ACA----A--A---G--C-GC-CA-G--C----GT-A---A---A-C--T   700 
UTCVM-H2   631  ------T---G------ATCA---------A----------A----G-T--G-CT-----AG-AACC--A   700 
UTCVM-NH2  631  CTATGGAGAGCAGTGGTTCACTGCTGCCAAGCAAAAGTTAAGGGAAATGAAAAACTTTGAGAGTGATACG   700 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  701  --C--G-----AG-A----C------C--C-----C--GC-TC-A-----T-----------T--AT-A-   770 
UTCVM-NH3  701  --------C--A-----C-CC--C--T------T-GA-GC-GA-T-----T--------------CC-T-   770 
USDA       701  --T--------A-----A-CT--C--C------T-G-----G-----T--C--C-----C-----C--A-   770 
UTCVM-H2   701  --C--------AG----G-CT--C--T-----AT-G-----TA----T-----------C-----T--T-   770 
UTCVM-NH2  701  CTAAAACCTCTTATTGGTGGATTTATAGATGGTCTACGATTCTTGACCGTGGATAACCCAAACCCGATGG   770 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  771  ----T--A------T-A--T-----GA-------AT-A---C----C-----A-----C--C--------   840 
UTCVM-NH3  771  -C-----------GT-A--TA-T--AA-------TT-A--CC----T-----C-----C--C-----G--   840 
USDA       771  -C-----T--C--G--A--T--CT-AA----------A--C-----C-----C--------C-----G--   840 
UTCVM-H1   771  -C-----------G--A--T-----GA-C------T-A--CC----------------------C--G--   840 
UTCVM-H2   771  -C--T--T--C--GT-A--T--C---A--------T----------------A--C--C--------G--   840 
UTCVM-NH2  771  GTTTCCTCCCAAAACTCATAGGACTTGTAAAACCCCTGAATTTGGCAATGATTATTGATAATCATGAAAA   840 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1  841  ---GC-G--G--G---G-AG----TC-C--A-----C--------T-----T-----T--C--------T   910 
UTCVM-NH3  841  ----G----A--A---G-A--A---C-C--T--T--T-----A--C--TGGG--T--T--T--T--T--T   910 
USDA       841  T--TA-T-----T-----TG-A---C-C--A-----T-----AT-G--T--------T-----T--A--T   910 
UTCVM-H1   841  ---C--G-----A---G-TG-A--GC----T-----C--------------T--T--T--T-----G--T   910 
UTCVM-H2   841  ----C----G--A-----TG-----C-C--A-----C------T-G--T-----T--T--T-----A--T   910 
UTCVM-NH2  841  CACATTATCTGGCTGGATCATCACATTAACCGCAATAATGGAGCTATACAACATCACCGAATGCACCATA   910 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  911  -----A---------T-A--C--A-G---------C---C--A----A--TC-------C-TT--CCAA-   980 
UTCVM-NH3  911  -----C--C--C--GC-A--C--CA-----------C-GC-A--G--ACT-C-A--G-----T--CCAA-   980 
USDA       911  ---G-GG-G--T---C-A--C--AA-C--T--------G--------A-----------C-----CCAA-   980 
UTCVM-H1   911  --C--C--C--TG--C-GG-C--A-G------------G-----T-----T--------C-TT--CCAG-   980 
UTCVM-H2   911  --C--AG--------C-G--C--C-GG--------C---C---CT--------TCGG-----T--CCAG-   980 
UTCVM-NH2  911  GATATTATAACATCAGTCATTACGGCTTTCTATGATAAAATTGGCAAGGCAACCAAATTTTACAGTTGTG   980 
                                                                                         
                         .         .         .         .         .         .         .        
UTCVM-NH1  981  -----AAT-------TG---------G-A-----T--GT-A--------------------T-----AG-   1050 
UTCVM-NH3  981  -G--A-GAT-A-----A--G--C-----G--A--T--GT-A--C--------------------G--C--   1050 
USDA       981  -------------------GA-----A-A-----T--G--A--C--G--C------------------G-   1050 
UTCVM-H1   981  -C--A--A--A----T---G--C-----------T--G--T--C--A--C-----------T--G-----   1050 
UTCVM-H2   981  -G---AAC--C--------C------G-------T--CT-A--C--A--C-----------T--T--TG-   1050 
UTCVM-NH2  981  TTAAGGCGCTGTTCACTGGATTTAGATCTGAGGACGTAGCGAATTCCTTTTGGTACATGGCAGCAGCGAT   1050 
                                                                                         
                         .         .         .         .         .         .         .        
UTCVM-NH1 1051  -T----------A-----------G----------------T----------------A-C--------T   1120 
UTCVM-NH3 1051  CT----C-----A--------TC-----------------------------------------T--T-T   1120 
USDA      1051  -T-------------T--A-----G-----G-----C--T-----------------G--C---T--T-T   1120 
UTCVM-H1  1051  C--G--C--T--A-----------G--T--------C-----------------T--G--C---T--T-T   1120 
UTCVM-H2  1051  ---G-----------T--C--A---C-------------A-----------A--C-----A--T---T--   1120 
UTCVM-NH2 1051  TCTATGTTACCTGATCACTGGGTTAATCCCAAACAATGGCAGGTTTTCAAAGATAAAAGCTTGCCTGGCC   1120 
                                                                                         
                         .         .         .         .         .         .         .        
UTCVM-NH1 1121  --C--AT----A--G--G---------A----T--------A-----A--------T-----------T-   1190 
UTCVM-NH3 1121  --G--C-----AT-A--G--T------A-G-----C-----A--T-----T-----T-------------   1190 
USDA      1121  -----T-----C--C--G-----G--CA-G--T--C-----A--T--A--------T-------------   1190 
UTCVM-H1  1121  --T--AT-C--GT-G--G-----A---A-C--T--T-----A--G--A--C-----T--C--------T-   1190 
UTCVM-H2  1121  --T--A--C--A-----G--T------A-C--T--T--G--A--T--A--------T--TG-------T-   1190 
UTCVM-NH2 1121  GGAGCGACAACTCTTGTATCAGGTATAGTTGCCACACAAAAGCTAGCTGCAATGTTCGCAACATGGAACT   1190 
                                                                                         
                         .         .         .         .         .         .         .        
UTCVM-NH1 1191  -------A-----A--C---C-A--C-----G--------A--C-----AT-------C--------C--   1260 
UTCVM-NH3 1191  ----A-----A--G-----GC----------G--------A--C--T---T-------C--------C--   1260 
USDA      1191  -------------C-----GC-A--T--------------AT--------T----T--C--C-----C--   1260 
UTCVM-H1  1191  -G-----G-----A--C--GC-A--T-----G--------A-----T--AT-------C-----C--C--   1260 
UTCVM-H2  1191  -G--A--A-----C------C-C--C--C--G--G-----AT-G--T-----C--T--C--T--T-----   1260 
UTCVM-NH2 1191  CTGAGTCCATTGTTAATGAATTGTCAGCAAGAACTGTTGCCCTATCAGAGCTGAACAATCCAACAACAAC   1260 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 1261  A--------T-----C--T------T-A--T-----------------------A--A-----AG----C   1330 
UTCVM-NH3 1261  ---------T--C-----T---A--T-AT-----C-------------A-----A--A--A--AG-A--C   1330 
USDA      1261  A--------T-----------G--GT----G-----------------A-----A--A--T---G----C   1330 
UTCVM-H1  1261  C--A-----C--C--T--T-G-A-G---T----G-----C--A-----------------T---G-G--C   1330 
UTCVM-H2  1261  A--------A--C--T------AAGT--T-------------------------A--A-----AG----C   1330 
UTCVM-NH2 1261  GTCTGACACGGATTCAGTAGAACGACTGCTAGAATTGGCTAAGATCTTGCATGAGGAGATCAAGATTCAT   1330 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 1331  -----------A-----------------------T--------CC-G--------TC-T--T-----A-   1400 
UTCVM-NH3 1331  --CT----T--T-----------------C-----TC-------------------T--A--T--G----   1400 
USDA      1331  --C--G--T--A-----------------C------C-T--G-----------T--AC-A--T--G----   1400 
UTCVM-H1  1331  --A--------A--T-----------------T---C-C--G---C-T--------------T--C--G-   1400 
UTCVM-H2  1331  --A-----T--T--A--------------C-----TC----G-----G--------A--A--T--G----   1400 
UTCVM-NH2 1331  ACTCTAAACCCCATCATGCAATCATACAATCCAATCTTGAGAAATTTAATGTCAACCTTGGACGGTGTTA   1400 
               
                         .         .         .         .         .         .         .       
UTCVM-NH1 1401  -C--------T-----A--A--G-----A--G--A--------A--T--------C-----CC-T-----   1470 
UTCVM-NH3 1401  -C-----G--------------G---------AAA--------A-----G--G--------TC-------   1470 
USDA      1401  -T--A--T--------A-----G--A-----G-----A--G-----C--------C-----TC-C-----   1470 
UTCVM-H1  1401  ----A-----------A--A-----------AA-A--A--G--A--C-----G-----T--TC-C-----   1470 
UTCVM-H2  1401  -G--A--T--------A-----G--A-----G--A-----G-CT--C-----G--C-----TC-C-----   1470 
UTCVM-NH2 1401  TAACTTCATGCAACAAGAGGAAAGCTATTGCTCGGAAGAGACAGGTGCCAGTTTGTTACATATTAACTGG   1470 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1471  G-----A--G--C-----------T--C--A-----GC-G--A-----G--A--A--C--------A---   1540 
UTCVM-NH3 1471  A-----------C-----------G--C-----------G--A-----GC-T--C-----------A--T   1540 
USDA      1471  A--C-----T--------G-----A--T--------GC----A--------A--A--------A--A--C   1540 
UTCVM-H1  1471  A-----------C--A--------G--C--C-----GC----A-----------A--C--G--A--A---   1540 
UTCVM-H2  1471  A-----A--G--C--C--G-----T--T--A--T--CC-C--A------C-T-----G--G--A--A--C   1540 
UTCVM-NH2 1471  CCCACCTGGATGTGGGAAAACAACCGCAGCTCAAGCATTAGCCAAGAAATTGTCTGATCAAGAGCCGTCG   1540 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1541  -----C---T-A-----G-----C--------T--C-----C-----A--C--C-----------A----   1610 
UTCVM-NH3 1541  -----C--T--------G--C--C--------------C-----C--A--G--C--T--A-----A----   1610 
USDA      1541  --------T-----------C-----------G--C-----C-----A--G--------------A----   1610 
UTCVM-H1  1541  --T--A---T-G--------C--------T--G--C-----C--C--A--G--------C----------   1610 
UTCVM-H2  1541  A-C--------------------C-----------C--A--C-----A--G-------------------   1610 
UTCVM-NH2 1541  GTAATTAACCTTGATGTTGATCATCATGACACATATACTGGAAATGAGGTATGTATCATTGATGAGTTTG   1610 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1611  ----C--------A--G--T--------------A-----------T--T--G--A--A-----T-----   1680 
UTCVM-NH3 1611  -C--C-----T-----T--T--------C-----A--A--A-----T--T--A-----C-----TC----   1680 
USDA      1611  -C-----------A--G-----C-----------A-----------C--T--G--C--A-----T-----   1680 
UTCVM-H1  1611  -C--A--A-----A--T--T--------------------A-----A--------C--A-----A--G--   1680 
UTCVM-H2  1611  -C--------T-----T-----------C-----T-----A-----A-----G-----------TC-C--   1680 
UTCVM-NH2 1611  ATTCGTCTGACAAGGTAGACTATGCAAATTTTGTGATTGGGATGGTGAACTCTGCTCCTATGGTGTTAAA   1680 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1681  ------T---T-G--G------------T-G-----T--------C--C--A-----A--A--T------   1750 
UTCVM-NH3 1681  ------T---T-A--G--T--A--------A-----A-----A--C--C--A-----A------------   1750 
USDA      1681  ------T---T-G-----T--A-----AT-G-----A-----------C--A-----C--A--T------   1750 
UTCVM-H1  1681  ------T--------------A-----AT-G-----A--C--A--------C-----C--A--T-----G   1750 
UTCVM-H2  1681  C-----T-----------------------T--T-----T--A--------C-----C-----T--G---   1750 
UTCVM-NH2 1681  TTGTGACATGCTTGAAAACAAGGGAAAGCTCTTCACCTCAAAGTATATAATTATGACTTCCAACTCTGAA   1750 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1751  --A--T--T--G--A-----A-----T--T--T--G------A-G-----C--C--T--T--C--G--C-   1820 
UTCVM-NH3 1751  --------C--G--T-----T-----T--T--------------G-----C--A-----------T--C-   1820 
USDA      1751  -----T--C--G--AAG-AG------T-----T--C--T-----G-----------------C--T----   1820 
UTCVM-H1  1751  --------------T--AAG---------T-----C--T-----G--------C-----T-----T----   1820 
UTCVM-H2  1751  -----T--A-----AG-A--A-----------T--------------------G--A--T--C--G--C-   1820 
UTCVM-NH2 1751  ACTCCAGTGAAACCCTCTTCCAAGCGCGCAGGCGCATTCTACCGAAGGGTTACTATCATCGATGTAACTA   1820 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1821  -----C-T-C---A--T--------C--CC-T--------AG----C--C--C--T-----C-----G--   1890 
UTCVM-NH3 1821  ----------------------------TC-C-----A--C--C--C--A--C--T--T-----------   1890 
USDA      1821  ----CC----------C-----A--C--TC-C-----T--A-----C--C--------------------   1890 
UTCVM-H1  1821  ----AC----T--------T---------C-A-----A--A-----C--A--------------A--G--   1890 
UTCVM-H2  1821  ----AC-------A--C-----------CC-T-----TT-TG-------AA-A--------C--A--G--   1890 
UTCVM-NH2 1821  ACCCTTTGGTGGAGTCGCACAAGCGTGCAAGGCCTGGGACGTCTGTTCCTCGTAGCTGCTATAAGAAAAA   1890 
 
Figure (4.1) continued 
 
 44 
                         .         .         .         .         .         .         .   
UTCVM-NH1 1891  ---T-----------------A-----C-----A--A--T-----T--A--G--T--A--G-----C---   1960 
UTCVM-NH3 1891  ---T--C-----G--G--------G--T--T--T-----T-----T-----G--T--C-----T--C---   1960 
USDA      1891  ---T--------T--TT-G----GG--T--A-----A--------------G--T-----G-----C--A   1960 
UTCVM-H1  1891  T-----C-----A--T--------G--T-----------------T-----T-----GT-G---------   1960 
UTCVM-H2  1891  ---T--C--C--G--G-----------T-----T--A--T-----T--A--G--T--C--------A---   1960 
UTCVM-NH2 1891  CTTCTCTCATCTCTCACTTGCTAAACGAGGGGCCGAGTGCTGGTGCAAGGAATACGTTCTTGACCCTAAG   1960 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1961  -----G-----T----C---A--A-----A-----C--T--C--C-----A--T---C----A--A--C-   2030 
UTCVM-NH3 1961  --A--C--------G-----C--------A--------T--C-----T-----------------A--T-   2030 
USDA      1961  --T--C-----T---TCA--A--------T--C-----T--CT-A--------------------A----   2030 
UTCVM-H1  1961  --------G--T--GTCT-CT-----A-----C--A-----C-----------------------A--T-   2030 
UTCVM-H2  1961  --C--------T---TCT--C-----C-TT-T---A--T-CCT-A--------T-----------A--T-   2030 
UTCVM-NH2 1961  GGGCTTCAACACCAAAGCATGAAGGCTCCCCCTCCTACCTTTCTTAACATTGACTCTTTAGCTCAGACAA   2030 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 2031  ----A--G--T---ACT--G--A--------T-----A--A-----G--A--TAGT--C--C--T-----   2100 
UTCVM-NH3 2031  -------G------GC-G-G-----------------T--G--G-----T--TAGT--------G-----   2100 
USDA      2031  -------------TGCA--A---------T-A--------A--G--A--C---AAT--T--C--------   2100 
UTCVM-H1  2031  ----A-----T---G-T--G--A--------T-----AC-A--G-----C---T-T--G--C--C-----   2100 
UTCVM-H2  2031  ----A--G------ACCT-G---------T-------A-----G-----T--TAGT--C-----T--C--   2100 
UTCVM-NH2 2031  TGAAGCAAGACTTCTTGCTCAAGAACATGGCCTTTGAGGCTGAAGATGGGTGCGCAGAACATCGATATGG   2100 
       
                         .         .         .         .         .         .         .      
UTCVM-NH1 2101  A--T--------G--ATCG-----C-----A--C-----AT-A-----T--CA-C----TT--AC-C--C   2170 
UTCVM-NH3 2101  ---T-----C-----A--T--------G------------T-A-----T--CA-A----TT---C-CGGC   2170 
USDA      2101  T--T--------------C--------G-----------AT-G-----T--T-----A--T---C-C---   2170 
UTCVM-H1  2101  C--T--T--------A--G-----C--G--C--C--------T--T--T--CA-AC---TT---C-C---   2170 
UTCVM-H2  2101  A--T--T--C--GAGA------A-A--G-----C-----A-----A-----T-----AA-----C-T--C   2170 
UTCVM-NH2 2101  GTTCGTGTGTCAACAGGAAGAGGTTGAAACTGTTCGCAGGCTCCTCAACGCGGTTAGGGCAAGGATGAAT   2170 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1 2171  --A--A-----------------T--A--AG----CAG---A--A--------G--A-----TC-T----   2240 
UTCVM-NH3 2171  --C-----T--------C-----C--G---G----TAG---AG-A--G--T--G--T--T--CC----C-   2240 
USDA      2171  --A--A--T-----T-----C-----T---G-T--TA----C-----C--------T--T---C-C--C-   2240 
UTCVM-H1  2171  -----T--T--A--A--------G------G-T--CA----CG----------C--A--T---C----A-   2240 
UTCVM-H2  2171  --A-----T--A--T-----A--C--T---G-T----CA--AG-A--G--------C--T--AA-C--C-   2240 
UTCVM-NH2 2171  GCTACCTTCACTGTGTGTGTTGGACCCGAGACCTCGCACTCGATTGGTTGCACTGCGCACGTGTTAACTC   2240 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 2241  -TG-T--AC-A--C--C--G--------C--------T--C--C--------G--G--GG-------G--   2310 
UTCVM-NH3 2241  -AGGG--AC-G-----C--G--A--------G-----T--T--C--T--G---------G-C--------   2310 
USDA      2241  -TG-G---C-A--C--C--G--------C--G--C----------G---G--G------G----AT-A--   2310 
UTCVM-H1  2241  --GGT--AC-A--C-----C-------A---G------A----------G--C------G-A---T-G--   2310 
UTCVM-H2  2241  -TG-T--AC-G--C-----G--A-GA--C--C--T--C--T--C-----G--T--G--A--A--A-----   2310 
UTCVM-NH2 2241  CCAACGAGACCTTTAATGGAAAGAAGTTTGTTGTGTCACGATGTAACGAAGCATCACTTTCTGCCCTTGA   2310 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 2311  ------------TC-A--T--AC-----A-T--C-----CA-------CT-AGT---CC----T------   2380 
UTCVM-NH3 2311  G--C--T-----CC-A--T--AC----------C-----CA-C-----C--TGT---CC-T---------   2380 
USDA      2311  ---A-----C--TC-A--T--A-----GA-A--C-----TA-------C-----C---C-A---------   2380 
UTCVM-H1  2311  ---G--T-----GC-A--T--G-----A-----------TA-C-----------A---C-A--T------   2380 
UTCVM-H2  2311  ---A-----C--CC----T--AC-A--T--A--C-----T--C------T-A--C--C------------   2380 
UTCVM-NH2 2311  AGGTAACTGTGTAAAGTCAGCCTTGGGCGTGTGTATGTCAGATAAGGATCTCACTCATTTGTGCCACTTC   2380 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 2381  --A--G--A--G---A-------------C-----A--C-----------------A-------------   2450 
UTCVM-NH3 2381  ----GG-----------------------------A--------------------A-------------   2450 
USDA      2381  ----G------G--C--------T---------C-C--------------------A-------------   2450 
UTCVM-H1  2381  --A--------G-----------T-----C--------------------------A-------------   2450 
UTCVM-H2  2381  --A--G-----------------T--------------------------------A-----------T-   2450 
UTCVM-NH2 2381  ATTAAAGGGAAAATTGTCAATGACAGTGTTAGGTTGGATGAACTACCCGCCAATCAGCATGTGGTAACCG   2450 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 2451  ----C-----------------------------------C--GT----------A-----T-----A--   2520 
UTCVM-NH3 2451  ----C-----------------------------------C--AT-----A----A-----------A--   2520 
USDA      2451  ----------------C-----------------C--A--C--T-----A----------AT-----CG-   2520 
UTCVM-H1  2451  ----C-----------------------------C--A--C--G-----AA-T--A-----T-----G--   2520 
UTCVM-H2  2451  -------A--T-----------------------C-----C--------AT-T--------------C--   2520 
UTCVM-NH2 2451  TTAATTCGGTGTTTGATTTGGCCTGGGCTCTTCGTCGTCATCTCACACTGGCAGGGCAGTTCCAAGCTAT   2520 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 2521  ---------------------------------T--------C--T---C----A--T-----------A   2590 
UTCVM-NH3 2521  ------------------------------T------------------C----A---------------   2590 
USDA      2521  ---G-----------C----------C---T------G-T-----T---C--A-G--------------T   2590 
UTCVM-H1  2521  ---------------------G--------------A---------------A-A---------------   2590 
UTCVM-H2  2521  --AG-----------------G----C---T-----AG-A---------C--A-G--------------C   2590 
UTCVM-NH2 2521  CAGAGCCGCATATGATGTGCTTACTGTCCCCGACAAGATCCCTGCAATGTTGCGTCACTGGATGGATGAG   2590 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 2591  --T--G--C-----------T-----T--------CA----T--G--A-----T--G--T--T--A--A-   2660 
UTCVM-NH3 2591  --G--------A--C--G--T--C--C-----G--------C--A-----T--C--C-----T--A--G-   2660 
USDA      2591  -----------A-----G--T--C--C--C--G---A-------C-----AG-G--G-----T-----G-   2660 
UTCVM-H1  2591  --A-----C-----------T-----C--G--G--------T--------A--T--------A-------   2660 
UTCVM-H2  2591  --A-----C--A--C--G--T-----C--C--G-----------A-----G--T--G--T--T--A--A-   2660 
UTCVM-NH2 2591  ACCTCCTTTTCTGATGAACACGTTGTAACACAATTTGTAACACCTGGTGGCATAGTTATCCTGGAGTCTT   2660 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 2661  -T--C-----------T-----GC-G-----------------G--C-----C--T--T--C--G-----   2730 
UTCVM-NH3 2661  ----------G-----------GC-G--------------------C-----C--G-----T--A--GGT   2730 
USDA      2661  -T---------------------C-G--C-----T------A----T-----------T--C--A---GT   2730 
UTCVM-H1  2661  -T--------G-----------GC-G--------T-----T--G--T-----------T--C--T--G--   2730 
UTCVM-H2  2661  -T--------G--------------G-----------------T--T-----C-----T--C--A--C--   2730 
UTCVM-NH2 2661  GCGGTGGTGCACGCATCTGGGCTTTAGGTCACAACGTGATCCGAGCAGGAGGTGTCACCGCAACCCCAAC   2730 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 2731  ---G---A----------G------C-A-----T-A---A----------TT--A--T--C--G--A--T   2800 
UTCVM-NH3 2731  T--C--T-C-A-C--A--G-----CC-A--C----A---A-----------T--A-----C-----A---   2800 
USDA      2731  T--T---A-------A--G-----TC-C-------A---A-----------T--A-----C---------   2800 
UTCVM-H1  2731  T-----G-----------G-----TC-C--G--T-A---------------A--A------A-G---T--   2800 
UTCVM-H2  2731  T--T--G---------C-------TC-C------A----A-----G-----T---C-G-----------G   2800 
UTCVM-NH2 2731  CGGAGGATGTGTTAGGTTAATGGGATTGTCTGCCCCAACCATGCCATGGTCCGAGATCTTTCGTGAGCTC   2800 
                  
                         .         .         .         .         .         .         .      
UTCVM-NH1 2801  -----A--TC----A-----C-----CAG---T--G-----CA-T--T--T-----C--A-----C----   2870 
UTCVM-NH3 2801  ---------C-T--------C-----TAG------G--T--CA-T--T--CT-------------T----   2870 
USDA      2801  --T--A--TC-G--A-----------TAG---------T---A-T--C-----T--C--------T----   2870 
UTCVM-H1  2801  --T-----TC-G-----G--C-----TAG-A-T-----T---A----T--T--T--A--C--A--T----   2870 
UTCVM-H2  2801  --------GC-G-----G--C------AG---T-----T---A-T-----T--C-----------T--C-   2870 
UTCVM-NH2 2801  TTCTCTCTCTTAGGTAGAATTTGGTCATCTGTCAAAGTATCAGCCCTAGTGCTAACTGCTCTTGGAATGT   2870 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 2871  -T-----C--G--------------A--------------G--A----CT--A------C-C--------   2940 
UTCVM-NH3 2871  -T--------------G--------T-----------G-----A----CC---CACA-CT-C--------   2940 
USDA      2871  -------A--G-----G--------T--G--T--------G--A----CA---G----GC-T--T--A--   2940 
UTCVM-H1  2871  -------A-----C--G--------T-----------G----------CA--A-----TC-G--TC-T--   2940 
UTCVM-H2  2871  ----T---------C----T-----T--G--C---------------AAC--A-C--   -----C-A--   2937 
UTCVM-NH2 2871  ACGCATCTAGATTTAGACCAAAATCGGAAGCAAAAGGAAAAACCAAATTGAAGATTGGAACATACAGGGG   2940 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 2941  C--T--A--T--T--C--T-----T--A--T-----A---A-A--G-----T--AA--------------   3010 
UTCVM-NH3 2941  ---T--A--C--T--C--T-----T--------T------A-A--G-----T---A-T------------   3010 
USDA      2941  ------C--C--A--C--T-----T-----T--T------A-A--------T---A-------G------   3010 
UTCVM-H1  2941  C--T--G-----T--C--A-----T--A--T-----A---A-A--G--T--T---A-GC----G--A--C   3010 
UTCVM-H2  2938  GA-G--A--T--A--C--T-----T--A--T--T-----------G--------TA-A--G---------   3007 
UTCVM-NH2 2941  TCGCGGTGTAGCGCTGACCGATGACGAGTACGACGAGTGGCGCGAACACAACGCCTCCAGAAAATTGGAT   3010 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3011  -----C--G--A------C-------A--T--------T--AT----G--T--T---GCT-----T----   3080 
UTCVM-NH3 3011  A-------G--A------C-----C-A-----C--C-----AT-G--T--T--T---GCT--C-----G-   3080 
USDA      3011  C-C--T--T--A--C--------------------C--A--GT-G-----A--T--TGCT-----C--C-   3080 
UTCVM-H1  3011  C-A--T--T--A------C-------------------------T--T--T--T---GC---C--G--T-   3080 
UTCVM-H2  3008  --------G--A--C---C-T---C----A--C-----T--C--T--T--A--T--TGCT-----C--T-   3077 
UTCVM-NH2 3011  TTGTCAGTAGAGGATTTCTTAATGTTGCGCCATCGTGCCGCTCTAGGAGCCGACGACAACGATGCAGTAA   3080 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3081  -----A-A--C-----------A--GT-A---T----TG----C-T---A-----------------A--   3150 
UTCVM-NH3 3081  ----TA-A--C-----------A--GT-ACG-T----AG-C--C-T---T--C-----T-----C-----   3150 
USDA      3081  -G--TA-A--A--------T--A---T--CG-T----TG----C--C-----C--------G--------   3150 
UTCVM-H1  3081  -----A-A--A------------------CGCGCT-GTG-------------C-----T--T--------   3150 
UTCVM-H2  3078  ----TA-A--------------A---T-A---T----AG-C----T------------T--G-----A--   3147 
UTCVM-NH2 3081  AATTCCGGTCGTGGTGGAACTCCAGAACCAAAATGGCCAATGATTATGAGGATGTCACCGTAATTGGCAA   3150 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 3151  ------T--A--------G-GA--T--G-----C-----C-----------C--A--C-----T--A---   3220 
UTCVM-NH3 3151  G--------A--G-------GAG-TC--------G-G--C-GG--A--T-----G-----C--T------   3220 
USDA      3151  ------------------G--A--T-----A--C--A--C--G--A--C--------C-----T--T--T   3220 
UTCVM-H1  3151  ---------T--------G--A--TC-------------G-GG--------C--C--------TA----T   3220 
UTCVM-H2  3148  ------T--G--G-----G--A--T-----A--C-----C-G------A--------------T--A---   3217 
UTCVM-NH2 3151  AGGTGGCGTCAAACATGAAAAGATCAGAACCAATACCCTAAAAGCTGTGGATCGTGGTTATGACGTCAGC   3220 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3221  --C-----A-----T--C--C-----A--A-----------------------------T----------   3290 
UTCVM-NH3 3221  --------------T--T--T--A--A--A--T-----A--------------------T-----C--C-   3290 
USDA      3221  --------------T--C--T--T--T--A--T--------C-----------A-----T-----G----   3290 
UTCVM-H1  3221  --C--------G--T--T--C-----T--A--T-----------C--------------T----------   3290 
UTCVM-H2  3218  -----A--A-----T--T--T--T--A-----T-----A-----------C--------T-----A----   3287 
UTCVM-NH2 3221  TTTGCTGAGGAATCAGGACCAGGCACCAAGTTCCACAAGAATGCAATTGGATCTGTCACAGATGTTTGTG   3290 
                                                                                        
                         .         .         .         .         .         .         .       
UTCVM-NH1 3291  -C--------G-----T---G----------A-----C--G--T--G--A--T--C--T-----G-----   3360 
UTCVM-NH3 3291  -T--A---------------G----------T-----A--C--T-----T-----A--T-----C-----   3360 
USDA      3291  ----A-----G--A-----C--C--T-----T-----C--A-----T--G-----A--T-----G--G--   3360 
UTCVM-H1  3291  -A--A-----G--A--T---G----------T--T--G--C--T--C--T-----A--T--A--C--G--   3360 
UTCVM-H2  3288  -T--A-----G--T--T---G-G--------T--T--G--C--T--T--T-----------A--T-----   3357 
UTCVM-NH2 3291  GGGAGCACAAAGGCTACTGTATTCACATGGGCCACGGTGTTTACGCATCCGTGGCTCACGTGGTAAAAGG   3360 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3361  T-----C--C-----------GC-A--C-----CT-A--A--------G--------------C------   3430 
UTCVM-NH3 3361  A-----G--------------------C------G-G--A--------------------------T--T   3430 
USDA      3361  T--C--------------------A--C-----C--C--A--C-----A--------T--T--C--T---   3430 
UTCVM-H1  3361  T--C--T--C--TC-------------C--------A--A--A-----------T--T-----C--G---   3430 
UTCVM-H2  3358  A-----T-AC--TC-T--G-----A--C------T-G--A--------A--------T-----CA-G---   3427 
UTCVM-NH2 3361  GGATTCATTTTTCTTGGGTGAAAGGATTTTTGATCTTAAGACTAATGGTGAATTCTGCTGCTTTCGCAGC   3430 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 3431  --C--A-----A-----------T--C-----C-----T--A--------A--C--A-----T--A--T-   3500 
UTCVM-NH3 3431  --AC-C--CT-A-----------C-----------C--C--A--A--A-----C-----------A--G-   3500 
USDA      3431  --A-----CT-A-----------T--------------------T-----A--C--T--------A----   3500 
UTCVM-H1  3431  --A--A--A--C--C--------C--------------A--A-----------C--T--------T--G-   3500 
UTCVM-H2  3428  --A-----C--T--------A-----A-----C--G--A--A--A-----A-----A-----C-----T-   3497 
UTCVM-NH2 3431  ACGAAGATTCTGCCTAGTGCTGCACCTTTCTTTTCTGGGAAGCCCACTCGTGATCCGTGGGGATCCCCCG   3500 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3501  -T--------A-----------GGC------------A--C--G--A---G-A--C--T--------C--   3570 
UTCVM-NH3 3501  -A--------A--------C---CCC-----------A--A--------CG-------T-----C--T--   3570 
USDA      3501  -------C-----------G---GCC-----C--T--------G--A---G----A-----C--------   3570 
UTCVM-H1  3501  ----G-----------A--A--GGCT-----C-----A-----C--A---G-T--------C--------   3570 
UTCVM-H2  3498  -T-----A-----------A---CCC-----C-----A--A-----A---A-A--A--------------   3567 
UTCVM-NH2 3501  TGGCAACTGAGTGGAAGCCTAAAATGTACACAACAACCTCTGGAAAGATTCTGGGGTGCTTTGCAACAAC   3570 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3571  G-----------C--T--T--T--T-----GT-G-----C-----------T--A-----C--A------   3640 
UTCVM-NH3 3571  ---T--A--G--------T--T--T-----C--G-----C--C--------T--C-----T-----T--C   3640 
USDA      3571  C--C-----------T--T--T--T--------A-----C--------T--T-----A--C--T---T-G   3640 
UTCVM-H1  3571  A--C--C-----C--T--A-----T-----C--A-----C-----------T-----A--T--G--G---   3640 
UTCVM-H2  3568  A-----A--G--------A--T--------CT-G--T--C--------T--T--A-----T--T--A--A   3637 
UTCVM-NH2 3571  TTCAACTGAAACTCACCCGGGAGACTGTGGTCTCCCATATATTGATGACAACGGGAGGGTGACCGGCCTT   3640 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3641  --T-----A-----A--G--------T-----C--A---C-T--T--A--C-----T-------------   3710 
UTCVM-NH3 3641  --T--A--G--A-----T--------A--T-----A--AC-T--T-----T-----T--------T----   3710 
USDA      3641  --------A--C-----G--------T-----C--A---C-TA-T--A--------C-----C------C   3710 
UTCVM-H1  3641  -----C--G--C--------------T--------A--A-----A--G--C-----T-------------   3710 
UTCVM-H2  3638  --------G-----C--G-----------C--C--A--------T--C--G-----T--T-----T----   3707 
UTCVM-NH2 3641  CACACTGGCTCTGGGGGACCAAAAACCCCAAGTGCCAAGTTGGTGGTTCCATATGTGCACATTGACATGA   3710 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3711  -A--C-----A--------C--------T--T--G--A--A--------T-----------A--------   3780 
UTCVM-NH3 3711  ---AC-----A--A-----C-----A--T--TA-C--C-----C--C--------------A--------   3780 
USDA      3711  GC--A-----G-----G--C--G-----T---CC---A--------C--T--------G--GC-G-----   3780 
UTCVM-H1  3711  -A-A------T---T-G----------TT--T-A---A--A--------T--C--------A--G-----   3780 
UTCVM-H2  3708  --GAA-----A--------A--------T--T--T--A--A--A-----T--C--T-----G-----C--   3777 
UTCVM-NH2 3711  AGACTAAATCCGTCACTGCTCAAAAGTACGACGTAACGAAGCCTGATATAAGTTACAAAGGCTTAATTTG   3780 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 3781  ---------------------AG----T--------T--C--GT-G-----G--G-----T---------   3850 
UTCVM-NH3 3781  C--A-----------G--C--A--------------A--T-----T--C-----A--G--A--TGT----   3850 
USDA      3781  ------------------------C-----------A--C-----------T--G-----A--T------   3850 
UTCVM-H1  3781  C--A--------------C--A--C--------G-----T-----------G-----T--A--------A   3850 
UTCVM-H2  3778  ---------------------A--------------A---A-A--A-----T--------T--TGT---A   3847 
UTCVM-NH2 3781  TAAGCAATTGGATGAAATTAGGATTATACCAAAAGGCACACGTCTCCATGTCTCCCCAGCCCACACTGAG   3850 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 3851  ------G-G--------C--------T-----------T--T--T--------A-----------GT-A-   3920 
UTCVM-NH3 3851  ------G-G--------C--T-----A--C--T-----C--T--C-----A--A--------G--C--T-   3920 
USDA      3851  -----CG-G--G-----C--------T--T--GT-A-----T--T-----T--A--C--------A----   3920 
UTCVM-H1  3851  --C-TCAC---C-----C--T-----T--T-----G--C-----C--C---A-A--------------G-   3920 
UTCVM-H2  3848  ------G-------T--C--------T-----T--A--T--T--T-----TA-A-----C--G--A----   3917 
UTCVM-NH2 3851  GATTATCAAGAATGCTCACACCAACCCGCATCACTTGGAAGCGGGGATCCCCGCTGTCCAAAATCTCTCA   3920 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1 3921  -A-----T-----G--C--C--G-----------------A--------------C------A-CT----   3990 
UTCVM-NH3 3921  -G--A--C-----------C--G--------T-----C-----G--A--A--C--C--C--C--G-----   3990 
USDA      3921  -A--A--T-----------G-----------T--------AA----T--A--C--C--C--C--G--T--   3990 
UTCVM-H1  3921  -A--G--T-----------AT-G--G--G--T-----T--------A--C--A--C------A-CT----   3990 
UTCVM-H2  3918  ----A--T--A-----------G--------------T-----------C-----C--C---A--T-A--   3987 
UTCVM-NH2 3921  CTGCTATAGTTGTTGATTCTCTAAAACCATACTGTGAGAAGGTTGAGGGTCCTCCACATGATGTTCTGCA   3990 
                                                                                        
                         .         .         .         .         .         .         .       
UTCVM-NH1 3991  ---G--C---------T-G-----------C--T-----C--A--------T--C--T--T-----A---   4060 
UTCVM-NH3 3991  T--G--C---------T-G-----------G--T--------T--C--------A--A--T-----A--C   4060 
USDA      3991  TC-T--G-----------G-----------C--T--A--C--T--C-----T--A-----T--------C   4060 
UTCVM-H1  3991  ---G--A--G--A---T-G--A-----T--AG-T-----------C-----T--A--T--T------A--   4060 
UTCVM-H2  3988  TC-T------------T-A-----------A--T--T-----T--------T--C--T--T-----A---   4057 
UTCVM-NH2 3991  CAGAGTTCAAAAGATGCTTATTGATCACCTTTCAGGCTTTGTCCCTATGAACATTTCCTCGGAAACCTCT   4060 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 4061  -----T--T--------T--G--T--C-----C--C--T-----G-----T--A-----T--------G-   4130 
UTCVM-NH3 4061  -----T--T--C--T--T--G-----C-----C--C-----------C---C-A--T--T----------   4130 
USDA      4061  ---A-T--T--C--T-----G--T-----------A--A--------C--------T--GC-------G-   4130 
UTCVM-H1  4061  -----G--T--C--T-----G-----------C--G--T--C--G--G--T-----T--T--G-------   4130 
UTCVM-H2  4058  ---A----T--A--T-----G--T--C-----------T--C--G--T--TC-T-----T--G-------   4127 
UTCVM-NH2 4061  ATGCTCTCAGCTTTCCACAAACTCAATCATGATACTTCCTGTGGACCATACTTGGGCGGCAGAAAGAAAG   4130 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 4131  --------A-C--------A--T-------CTC--C-C--C--GT----AT----A--------------   4200 
UTCVM-NH3 4131  -------AA-C--T--G--A-----T--A-CAC-------CT-G-----CT-C--A-----------C--   4200 
USDA      4131  ---------TC--T--------A-------C-C-------C--GT----CT----A-----G-----A--   4200 
UTCVM-H1  4131  -C------AT---------A--CA----A--AC----------A-----CT----------------A--   4200 
UTCVM-H2  4128  --------AT---T-----A--T-----A-CAC-CC-A--C--T------T----A-----------C--   4197 
UTCVM-NH2 4131  ATCACATGGCTAACGGTGAGCCGGACAAGCAGTTATTGGATCTCCTGTCTGCAAAGTGGAAATTGGCTAC   4200 
                
                         .         .         .         .         .         .         .      
UTCVM-NH1 4201  A--------T-----G--C-----A-----CA----CT-G--A--T-----GC-A--T--T--A------   4270 
UTCVM-NH3 4201  T-----T--T--T--G-----C---------A----TT----A--T--AT-G--A--T--------A---   4270 
USDA      4201  T--------C--C--G-----C---------A----C--G---------T-GC----------A------   4270 
UTCVM-H1  4201  A--G-----T--CT-G-----C--A-----CA----C--G--A--T--AT--C-A--AA-T--A--A--G   4270 
UTCVM-H2  4198  ------T--T--C--G--T-----A------A----CT----A--T--A--T--A--T--T--A--A---   4267 
UTCVM-NH2 4201  CCAAGGCATAGCACTACCACATGAGTACACATTTGGGCTAAAGGACGAGCTAAGGCCCGTGGAGAAGGTT   4270 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 4271  GC---G-----A--G--A-----C-----A-----C--G--A--T--C-----G-----------T--T-   4340 
UTCVM-NH3 4271  GC------A--AC----------C-----G-----------A--T--C-----G--C--T-----T----   4340 
USDA      4271  TA------A--A--GC-T-----C-----C-----------G--T--A--C--T----------------   4340 
UTCVM-H1  4271  CAG--T--A--------------------------C-----G--G-----A--T-----T--A--C----   4340 
UTCVM-H2  4268  CAG--------A--GC-A-----C-----------C-----A--T--------G-----C-----A----   4337 
UTCVM-NH2 4271  AGTGAAGGGAAGAGAAGGATGATTTGGGGTTGTGATGTTGGCGTCGCTACTGTCTGTGCAGCTGCGTTCA   4340 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1 4341  -A-CA--C---G----A-----T--T--C--------T--A--CG-C--------A--A-----A--CG-   4410 
UTCVM-NH3 4341  ---CC------G----A-----T-----C-----A--T--C--CG-T--A-----------------C--   4410 
USDA      4341  -A--C--C--TG----A--T-----G--C--------T--A---G-C-----G--G------------G-   4410 
UTCVM-H1  4341  ----A--C--TG----A--T--T--C--C--------T--A-----C--A-----A--A-----------   4410 
UTCVM-H2  4338  -------C--TG----A--A-----T--C--T--A--T--C---G-T--A--------A--------CG-   4407 
UTCVM-NH2 4341  AGGGTGTTAGCTATGCCATCACAGCAAATCACCAGTACGGGCCTATACAGGTTGGTATCAACATGGATAG   4410 
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                         .         .         .         .         .         .         .     
UTCVM-NH1 4411  T--A-----T--G---T---A----C----T--G-----C--A--A--T--------T-----------G   4480 
UTCVM-NH3 4411  TT----T--T--G--C----AT---C----T--G--T-----A--A--C-----T--T-----C------   4480 
USDA      4411  ---T--T--T--G--A----A---GC-A--T---GCT--T--A-----T-----C--T--C--C--A---   4480 
UTCVM-H1  4411  T--A--T-------TCT---A----C-A-----G--T--T--A--A--G-----T--T--C-----A---   4480 
UTCVM-H2  4408  G--T--T--T----------A------A-----G--T--T--------G-----A--T-----C--A--G   4477 
UTCVM-NH2 4411  CCCCAGCGTCGAAGCGCTGTTCCAAAGGATCAAAAGCGCAGCCAAGGTATTTGCGGTCGATTATTCCAAA   4480 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 4481  -----C-----T-----------A--T-----T--A--------------G--A-----------T--A-   4550 
UTCVM-NH3 4481  --------A--A--G--A--------T-----T--A-----------TT-G--G-----------TA-A-   4550 
USDA      4481  --------A--T--------A--G--------C--A-----------A--G--G-----------T--A-   4550 
UTCVM-H1  4481  -----C-----A-----T--C--C--T-----T--C-----------------A-----T--A--T--G-   4550 
UTCVM-H2  4478  --------A--T-----A--------T-----CT-G--C---------T-G--A--------C--T--A-   4547 
UTCVM-NH2 4481  TGGGATTCGACCCAATCGCCTCGTGTCAGTGCAGCTTCAATTGACATCCTTCGTTACTTCTCTGACCGCT   4550 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 4551  -------------T--G---G-G-----C-----A--T--A--A-----TG-G--C-----A--A-----   4620 
UTCVM-NH3 4551  ----T--A--------G--TA-C------T-A--------C--CA----T--A--------A--G-----   4620 
USDA      4551  -A-----C-----T--G--TG-C-----CT-A--A--T--A--C--A--C-----C--------------   4620 
UTCVM-H1  4551  -A--T--C--G--T--T---A-A-----C--A--------G---A-C--------C--------A-----   4620 
UTCVM-H2  4548  -G--C-----------T--AGTG--------A---TCT-----A-----------C-----A--G-----   4617 
UTCVM-NH2 4551  CTCCAATTGTTGACTCAGCCTCTAACACACTGAAGAGCCCTCCTGTTGCAATCTTTAATGGTGTTGCTGT   4620 
                                                                                        
                         .         .         .         .         .         .         .       
UTCVM-NH1 4621  T-----A--A-----TT-G--C--A--------G--------T--T-----C--------C--C--C---   4690 
UTCVM-NH3 4621  A--------A-----T--------A--------C--C--T--T--C--T-----A--C-----C-----C   4690 
USDA      4621  T-----T--T--A--AT-G--------------C--A--A--T--T--T--C--T--C-----C--CT--   4690 
UTCVM-H1  4621  C--A-----T-----GT-G--------G-----------G--T--C--T--C--T--C-----C---A--   4690 
UTCVM-H2  4618  T-----TA-A--A--T--------A--T-----CT-A--A--T--C-----C--A-----C--C------   4687 
UTCVM-NH2 4621  GAAGGTGTCCTCTGGCCTACCATCTGGAATGCCTCTTACCTCAGTAATCAATTCCCTTAATCATTGTCTG   4690 
                                                                                        
                         .         .         .         .         .         .         .       
UTCVM-NH1 4691  --------T--------CG-G--------G--------AAAT--C--T--A---------T-A-----TT   4760 
UTCVM-NH3 4691  --------T-----T--AA-G--G--T--T-----C---AA---C-----T--------T--C--T--C-   4760 
USDA      4691  --C-----A-----T--A--A-----T--G-------G-AAT--C--T-----------T--C------T   4760 
UTCVM-H1  4691  --------------T--C------G-T--C-----ACGTCAA--C--T-----------T--C-----TT   4760 
UTCVM-H2  4688  --------------T-----C--G--------G-----AAA---C--T--------------G-----CT   4757 
UTCVM-NH2 4691  TATGTTGGGTGTGCCATTCTTCAATCCCTAGAAGCTAAGGCCATTCCCGTCACTTGGAACCTTTTCTCAA   4760 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1 4761  -C-----C--G-----C-----T-----C-----G-----------A--G----T------CG-G-----   4830 
UTCVM-NH3 4761  -A--------G-----A--T--T-----------A--T-----C--A--G--------T---G-C-----   4830 
USDA      4761  ----C-----GC-A--C--T--T-----------G--T---C-C--A-CG----T---C---G-C-----   4830 
UTCVM-H1  4761  -------C--G--------T--T-----------G--T--------A-C-----T---T--C-------G   4830 
UTCVM-H2  4758  ----C--C--G-----------T-----------T-----------C--G----T-------G-------   4827 
UTCVM-NH2 4761  CTTTTGATATCATGACTTACGGGGATGATGGTGTCTACATGTTTCCTATTATGTATGCAAGTATTAGTGA   4830 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 4831  ---------C--C-----C--AG-A-----T--C-----C--CA-------T--AA-G-----T-----C   4900 
UTCVM-NH3 4831  T-----C--------C-----AG-T--T--T--A--G--T-----T--------A---A----T------   4900 
USDA      4831  T--G--A-----G--C-----TG-A--T--T--------C-----T-----T-----T-----------C   4900 
UTCVM-H1  4831  T-----C-----------C--TG----T--T--A-----C-----T--------A--T-----T-----A   4900 
UTCVM-H2  4828  ------------------G--CG-T--T-----C-----T---A-A--A--------T------------   4897 
UTCVM-NH2 4831  CCAAATTTTTGGAAATCTTTCGTCCTACGGCCTGAAACCAACTCGGGTTGACAAGTCCGTTGGAGCAATT   4900 
     
                         .         .         .         .         .         .         .       
UTCVM-NH1 4901  --A--A-----C-----A--A-----G--T--G--AC-C-----T--C--A--C-----C-----C--A-   4970 
UTCVM-NH3 4901  --A--C-----------G--------A---C-C--A-----T--A--T--A-----C-----A--C--A-   4970 
USDA      4901  --A--------C-----A--------A-----G--A-----------C--A--C--A--T-----T----   4970 
UTCVM-H1  4901  -----A-----C--A--A--A-----G--TC-C--------------C-----C--AA-T--T--C----   4970 
UTCVM-H2  4898  -----A-----C-----A-----G--A---C----A-----C----TG--A--T--A--T--AG----A-   4967 
UTCVM-NH2 4901  GAGCCTATTGATCCTGACTCTGTTGTTTTCTTAAAGAGAACAATCACAAGGACACCTCAGGGGATAAGGG   4970 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 4971  -GC--T-A--C--T-----------C--G--------C---A----------A--T--T-----T-----   5040 
UTCVM-NH3 4971  -C--G-----------T--A-----T--G--------C--CA-------------T--T-----T-----   5040 
USDA      4971  -G--GT-A--C-----T--A----CT-----G-----C--CA-C--G--A--A-----A-----T-----   5040 
UTCVM-H1  4971  -----T-G--------T--A-----T--G-----------CA-C-----------TA-A-----T---C-   5040 
UTCVM-H2  4968  -AC-------C--T--T--A--CC-T-----------C---A-A--------A-----T-----T-----   5037 
UTCVM-NH2 4971  GTTTACTTGATCGCAGCTCTATAATAAGACAATTCTATTATGTTAAAGGTGAGAACTCCGATGACTGGAA   5040 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 5041  A-A---C------ACA--------C--C--G--C--C-----A-----------A---T-A--T-----T   5110 
UTCVM-NH3 5041  A-C---A--C---ACA-----------T-----------G--A--C--------T-----A--T-----T   5110 
USDA      5041  A-CT---------ACA-----T-A-G-C--A--T-----G--------------T--CT-------C--T   5110 
UTCVM-H1  5041  A-C----------ACC--------C--G--C--T--C-----------------A--C-----T-----T   5110 
UTCVM-H2  5038  A-CA--A------ACC--A---G-TGTG--A-----C--------A--------T--CT----T-----T   5107 
UTCVM-NH2 5041  GAGCCCTCCAAAACATATTGACCCAACATCTCGAGGGCAACAGCTTTGGAATGCCTGTCTGTACGCTAGC   5110 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1 5111  --------TAGT-------A---------G----AAT----T----AA--G-----G--C----GA--C-   5180 
UTCVM-NH3 5111  ---------CA--------A------A----TG-AAT-----C-A-AA-----------------A----   5180 
USDA      5111  ---------G-T--A----A-----G---A--T-A-T----T----A---------G--C--G-GTT---   5180 
UTCVM-H1  5111  ---------ACA-----C-A---T--A--A-TA-AAT----AATA-AA-----G--G-----G-GT----   5180 
UTCVM-H2  5108  --------GG-T--A----A------A--G--T-AAT----T----AA--A-----G-GC---A-TT---   5177 
UTCVM-NH2 5111  CAACATGGCTTGGAGTTTTTCAACAAGGTTTACAGGCTGGCCGAGAGGGCTGTTGAATATGAAGAGCTGC   5180 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 5181  -T--------A--GT-C--CA-C-----------A--------------A--------T-----------   5250 
UTCVM-NH3 5181  -------T--T---T-T---AGC--A--------A-----------------------T-----------   5250 
USDA      5181  -TC-----GT-----AT--CAA--T---A-----A--A-------A--------GC--T-----------   5250 
UTCVM-H1  5181  -------------TGAT---AA------------A--------T-----A--------T-----------   5250 
UTCVM-H2  5178  -T--------A----AT---CAC--A--------G-------------TA--------------------   5247 
UTCVM-NH2 5181  ACTTTGAACCCCCAACATATGCTTCGGCTTTGGATCATTACAACAGCCAGTTCAATGGCGTGGAGGCGCG   5250 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 5251  ---C---------A-TAT------TG----------T-----C---------------------------   5320 
UTCVM-NH3 5251  ---C--T------A-TAT-----ATGCA------------------------------------------   5320 
USDA      5251  ---C--T------AGT-T-----ATG-A------------------------------------------   5320 
UTCVM-H1  5251  --GC--T------A-TAT-----ATGCA------------------------------------------   5320 
UTCVM-H2  5248  -A-------------T------------G-----------------------------------------   5317 
UTCVM-NH2 5251  GTCTGACCAGATCGACTCGAGTGGCATGACCGCCCTACACTGTGATGTGTTCGAAGTTTGAGCATGTGCT   5320 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 5321  -------------------------C----AC-----T--------C-GGC-T--T---G-------T--   5390 
UTCVM-NH3 5321  -------------------------C----A------T-----C-----G---A-T-----------T--   5390 
USDA      5321  -------------------------C--C-A------------CA---GG--A--G--TG-------T-G   5390 
UTCVM-H1  5321  ------------------------------A------------C----GG--AAATG-----------G-   5390 
UTCVM-H2  5318  -------------------------C----A------T-----CA-C-G------T-----------T--   5387 
UTCVM-NH2 5321  CAACCTGCGCTAACGTGCTTAAATATTATGGTTGGGACCCCCATTTTAAATTGGTAATCAACCCCAACAA   5390 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 5391  A--T--TT--------------GA------------------T--------------C--A---------   5460 
UTCVM-NH3 5391  A--T--AT-------A------GA------GC-T-----C--T---------T-G--C--T---------   5460 
USDA      5391  G--T--TT-----A-T--C---GA---G--AC-TC-T--------------C--A--C--A---------   5460 
UTCVM-H1  5391  A--T--AT-------T--C--CGAC--A--CC-T--------------C--GT-A--C--T-----C---   5460 
UTCVM-H2  5388  A--T--T---A----T--C---GA---T---C--------------------T-G--C--A-----C---   5457 
UTCVM-NH2 5391  CTTCCTCCCTGTTGGCTTTTGTAGTAACCCTTTAATGTGTTGCTACCCAGAACTCCTTCCGGAATTTGGA   5460 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 5461  --G--G-----C--T----A------G--GC----------G--------C--------------G----   5530 
UTCVM-NH3 5461  -----G---A----TA-C-AA--C-----GC-------------G--T--C--A--A--------G----   5530 
USDA      5461  --C--G---------A-C-AA--T-----G-----------T-----T-----------C--C--G---T   5530 
UTCVM-H1  5461  ---------------AG----G-C--T--C-----C--TT----------T--------------G---T   5530 
UTCVM-H2  5458  -----G--------T----AA--C-----GC----C-----G--G-----C-------------------   5527 
UTCVM-NH2 5461  ACTGTTTGGGATTGCGATCGGTCACCACTTGAAATTTACCTAGAATCAATACTTGGTGATGATGAATGGG   5530 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 5531  -------A-A---G--AA----T---TCA--C--A------------GACT-------G--G--C--T--   5600 
UTCVM-NH1 5531  TT--T--C-A---A--AA----------T--C--A--------T----A--AA-----G---C-C-----   5600 
USDA      5531  ----G--G--C--A--CA----------------A------------GAC-AG-----G--G--------   5600 
UTCVM-H1  5531  -C--A--GCAC--G--AA----T--T--T--C--T--C---------GA--AG-----G--G--C--T--   5600 
UTCVM-H2  5528  -T--A----AC--T--CA-------T--T-----A------------GAC-A---A--C--G--C-----   5597 
UTCVM-NH2 5531  CATCCACTTTTGACGCTGTTGACCCAGTCGTTCCCCCAATGCACTGGAGTGCTGCTGGAAAAATTTTCCA   5600 
               
                         .         .         .         .         .         .         .       
UTCVM-NH1 5601  A--C-----------G--T------T-CA-------CG-------AAA--CT--------AA----A--A   5670 
UTCVM-NH3 5601  ---T--T--T---A-C--T--------CA-T--C---G--------AAG-C------T--AA--T----A   5670 
UTCVM-H1  5601  ---C--T--T--G--C--------T--C--T--CAACC-------AAA--CT--------TA--------   5670 
USDA      5601  ------------A--C--T-----------T---AAC--------AAGG-CT-----T--AA-CT-A---   5670 
UTCVM-H2  5598  A--T-----T--A-----G-----TTT---A--AAA-G-A-----AAAG--------T--AAG-T----A   5667 
UTCVM-NH2 5601  GCCACACCCCGGTGTTCTCATGCACCATCTCATTGGTAAGGTTGCTGCAGGCTGGGACCCCGATCTGCCT   5670 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 5671  AACT-----T-G--A--A-----------C--T--CA-C--T--A-----G--------A--A-------   5740 
UTCVM-NH3 5671  --CT----G--G--A--T-----T--A--T--A--CA----A--A---------CCA-----T--G--T-   5740 
USDA      5671  ---T-------T-----T-----T-----T-----GT----T-----G-----C--------T--T--G-   5740 
UTCVM-H1  5671  ---T-C--CT-G-----------T--C--C------A----A-----------GC-T--G--A-------   5740 
UTCVM-H2  5668  TCCT-C--TT-G--A--A--------A--C--A--CA----T--A--G--T--TGC------T-------   5737 
UTCVM-NH2 5671  CTAATTCGACTCGAGGCGGATGACGGGTCAATCACAGCACCCGAGCAAGGAACAATGGTTGGCGGCGTCA   5740 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 5741  -T--C-----A--------A---G----T--A-----C-C---A-----A-----T-----C--------   5810 
UTCVM-NH3 5741  -T--------T--T--T--A-----TG-------G-----------T-----G--T--------------   5810 
USDA      5741  -T--A--G--T--T-----A--------T--A--------------A--A--G--T--C--C-----A--   5810 
UTCVM-H1  5741  -T-----G--A--TT-G--A------G-C-----------------T--C-----------C--C--A--   5810 
UTCVM-H2  5738  -T--CC----------T--A-----GG-------A--C-----AT-T--T--G--T-----C--------   5807 
UTCVM-NH2 5741  TCGCTGAACCCAGCGCCCAGATGTCAACAGCTGCTGATATGGCCACCGGGAAAAGCGTTGATTCTGAGTG   5810 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 5811  ---A--T--------A-----T-----T--T--------------A--------------G-----T---   5880 
UTCVM-NH3 5811  ------G-----T--T--C-----T--T-----------C--C-----G--T-----T-----A-----T   5880 
USDA      5811  ---------------A--C--T-----T-----------------------A-----C--G-----T---   5880 
UTCVM-H1  5811  ---A--C--------A--C-----A--------C-----C-----------------G--G--------T   5880 
UTCVM-H2  5808  -----A------T-----C--T--T--T-----C-----C---A-------A--------G-----G---   5877 
UTCVM-NH2 5811  GGAGGCATTCTTCTCCTTTCACACCAGCGTCAATTGGAGTACATCTGAAACCCAAGGAAAAATTCTCTTC   5880 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 5881  --------------G---C----T-----C-----TAC---T-----A-----T-----G--T-------   5950 
UTCVM-NH3 5881  ---------C-T--T--CC----T-----C-----CTCT--------A-----T--------T-------   5950 
USDA      5881  --G-----T-----A--AC-A--A--------C--T--G-----A--A--A--C--------T-----G-   5950 
UTCVM-H1  5881  --------AC-T-----CC----A-----T--C--T--G--T---T-A--A--C-----C--A-------   5950 
UTCVM-H2  5878  -----G--AC-G--A--CC-T--------T--C--T------T-AT----A--C--------T-----A-   5947 
UTCVM-NH2 5881  AAACAATCCTTAGGCCCTTTGCTCAACCCATATCTAGAACACCTTGCTAAGCTATATGTTGCGTGGTCTG   5950 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 5951  -C--T--------A-----------T-----G-----------C--G--A--A-----C-----A-----   6020 
UTCVM-NH3 5951  -C--T-----------G--T-----T-----A--------------G--A-----A--C-----CA----   6020 
USDA      5951  ----TG----T--------T-----T-----A--------------A--T---T-G--T--C--------   6020 
UTCVM-H1  5951  -G--TG-A--------G-----C--A-----T--------T--C-----------T--T--------C--   6020 
UTCVM-H2  5948  -C--T--A--T-----G--T-----------T--------------G--A--A--A--C--A--A-----   6017 
UTCVM-NH2 5951  GATCGATTGAGGTTAGATTCTCTATCTCTGGCTCTGGTGTCTTTGGTGGGAAGCTCGCAGCTATTGTTGT   6020 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 6021  G--A--A--AA-------T--T--A--C--A--T-----G--------------TC-A-----C------   6090 
UTCVM-NH3 6021  G--A-----AA-C--A--C--T--A--C--A--A--------------T-----G-----C---------   6090 
USDA      6021  G-----A-----CA-C--T--A--A--C--A--A-----C-----------C--TC-C------------   6090 
UTCVM-H1  6021  G--G--A--A--------T--T--A--C--C--A---T-G--G--T--T-----TC-A--------C---   6090 
UTCVM-H2  6018  C--A-----T--C-----T--C--A--C-----C--------------T-----G--------------A   6087 
UTCVM-NH2 6021  ACCTCCTGGGGTTGATCCAGTGCAGAGTACTTCGATGCTACAATACCCCCATGTCTTGTTTGATGCTCGT   6090 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 6091  --A--A-----T--C-----TA-A--------T--G-----T-----------T--C-------------   6160 
UTCVM-NH3 6091  --------G--T---------A----C--------------T-ATT-A--T--T----------------   6160 
USDA      6091  --A--------T-----------A--------T-----G-----T-------------------------   6160 
UTCVM-H1  6091  --A--A--C--C--C------A----C-----T--T-----T-AT--C--T--------------T----   6160 
UTCVM-H2  6088  -----T--------G-----T---C-C-----T--G--G-ATT-A--A--T-----C--A-----T----   6157 
UTCVM-NH2 6091  CAGGTGGAACCAGTTATCTTCTCTATTCCTGACCTAAGAAGCACCCTGTACCACCTTATGTCTGACACTG   6160 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 6161  ----T--T--AC----G--C-----T--C--C---T-G--T--C--------T------T-T--------   6230 
UTCVM-NH3 6161  -T--T--T--TC-T--A------A-T--C-----------T--C--A-----T------T-A-----C--   6230 
USDA      6161  -T---------C-C--A--C--------C--------T--------G-----T-G----T-T--T-----   6230 
UTCVM-H1  6161  ----A--T--TC-C--G--------------------G--T--C--T------------T-------A--   6230 
UTCVM-H2  6158  -T--T-----TC----A--A-----T--C--------T--T--C--------A-----A--T--------   6227 
UTCVM-NH2 6161  ACACCACATCCTTGGTCATTATGGTGTATAATGATCTCATCAATCCCTATGCCAATGATGCCAACTCTTC   6230 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 6231  ---T--C--CC-C--C--G--A--------A--G--------------------TT-G--A--T--T---   6300 
UTCVM-NH3 6231  A--A--C-----C-----T--------A--C--TG----------------------A--A-----T---   6300 
USDA      6231  ---A--------C-----T--A--T--------A--A--T--------C--T--A--A--A--C-----T   6300 
UTCVM-H1  6231  ---A--C--A--C--A--A--A--C-----A--A--G--T-----A--------GT-G-----C--T--C   6300 
UTCVM-H2  6228  ------------C-----T--A--T--A-----A--C--T-----A-----T--G--A--A--C--T--G   6297 
UTCVM-NH2 6231  TGGGTGTATTGTTACTGTCGAGACAAAGCCTGGCCCTGACTTCAAGTTTCACCTCCTTAAGCCACCCGGA   6300 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 6301  --C---T-------C--A--A--T--A--------G--A--A---T----C--A--T-----T--C---A   6370 
UTCVM-NH3 6301  --------G--T--C--A--AA-T--A--A--------C--A---T-T--C-----T-----T-----TA   6370 
USDA      6301  --C--------T--C--C--C--G--G--------G--C--A--GT-C-----C--------T--C--T-   6370 
UTCVM-H1  6301  --A-----G--------C-----A--------C--G--C--A--G-GC-----T--------T-----T-   6370 
UTCVM-H2  6298  ------T----A-----G--CA-T--------CC-G--C--TCG-T-C--C-----------T--A--T-   6367 
UTCVM-NH2 6301  TCTATGCTAACCCATGGTTCTGTCCCTTCTGATTTAATTCCCAAAACATCTTCGCTCTGGATCGGTAACC   6370 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 6371  -A--T-----T--T----A---C--------------C-----A-----G--T-----G--C--C-----   6440 
UTCVM-NH3 6371  -AC-----A-T-----------A--C--TG--A----C-----T--------T-----C-----------   6440 
USDA      6371  -GC-----A-C--T--------C-----A--------A-----A--------C--C-----C--C-----   6440 
UTCVM-H1  6371  -TC-----A-T--T--C-----------C-----A--C-----G--------------G--C--------   6440 
UTCVM-H2  6368  -TC-T---A-T-----C-----------A--------C-----G--T-----C--C-----C-----T--   6437 
UTCVM-NH2 6371  GCTACTGGTCAGACATAACTGATTTTGTGATTCGGCCGTTTGTCTTCCAAGCAAATCGTCATTTTGACTT   6440 
                                                                                        
                         .         .         .         .         .         .         .       
UTCVM-NH1 6441  C--------A-----T--C-----T------A-A-----T--A--TA-A--C--A------GTGA----G   6510 
UTCVM-NH3 6441  C--------A--G-----C-----T-----CA----CA----A--CA-------AG-----G-GA-A-G-   6510 
USDA      6441  ------G-----G--T--T--------G---A-A--C-----A--CA-AA-A--A------G-GA-----   6510 
UTCVM-H1  6441  ------G-----A--T--T--------C---A-A--------GC----G--C-----C-----GAGT-GA   6510 
UTCVM-H2  6438  ---------A--G--T--T--------G---A-A--CA----A--TA--A-A-AT--------GA-A--A   6507 
UTCVM-NH2 6441  TAATCAAGAGACCGCAGGGTGGAGCACACCACGGTTTCGACCTATATCTGTTACCATTAGTCAACAGGAT   6510 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1 6511  TCT-----GC-T--------T--------T--------T--T-----T--A--A-----T-----A----   6580 
UTCVM-NH3 6511  --CT----------A-----T--T--T--C----CA--T--C-----T--A--------T-----C----   6580 
USDA      6511  ---T-C--------A-----G--T----TG--C-CT--C--T--------A--G-----A-----A--T-   6580 
UTCVM-H1  6511  --T--C---C-T--A-----TA-T-----T--------C-----G-----T--A-----A-----A--T-   6580 
UTCVM-H2  6508  --C----GGC-T--T-CA-C-A-T---GTC---ACG--TT-A--C--G--A--A-----G--------T-   6577 
UTCVM-NH2 6511  GGAGCAAAATTGGGCATTGGAGTGGCAACAGATTACATAGTGCCTGGAATCCCTGATGGCTGGCCTGACA   6580 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 6581  -G--C--C--AACA--T----C---T-----T--C-----C------G--TCC-CG---A----------   6650 
UTCVM-NH3 6581  ---GC--CT-C-ACACTC-A--T---T-A--A--------A-------G-GGC-A---TA-C-----T-T   6650 
USDA      6581  -T--C--A----A-A----AG-C--T--------C--T--A---G-----GGG-C---AA-------T--   6650 
UTCVM-H1  6581  -A-----A--C------C---CT--T--A--------T--C--TGTT---C-G-A-AA-AG---T--AG-   6650 
UTCVM-H2  6578  ----C--A--AACT-T-C---CT--T-----TA-A--T--A-----ATCAGGC-ACAATAGC-----TCT   6647 
UTCVM-NH2 6581  CCACAATTCCTGGGGAGTTGATACCAGCTGGCGATTACGCGATCACCAATAATATTGGCGATGACATCAC   6650 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 6651  T--CC-C-GT-----C--TT-C--CAT-TCG--CGTT-----C-----T--C-G---T--------T---   6720 
UTCVM-NH3 6651  A--T-G-G-T-AT-----TT-G------G-G--C--------C--A--T--C-GAA-T--------T---   6720 
USDA      6651  T--A--C-A--AT-----TT-G--CAC-G-----C-A--------------C--A--T-----T--C---   6720 
UTCVM-H1  6651  A--AAAACAG-C---C--AT-C--CACATC---CG-A--T--C--A--T-----AA----------T---   6720 
UTCVM-H2  6648  A--TCGC-AT-AT--C--G-A-------G-C--C--------C--------C-G-A----------T---   6717 
UTCVM-NH2 6651  CACGGCTACAGGATATGACACTGCTGATATAATTAAGAACAATACCAACTTTAAGGGCATGTACATATGT   6720 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 6721  -----T--T--AA-G--A--------T------G----C-----C--A--C--------A-GG-T-G-C-   6790 
UTCVM-NH3 6721  -----C--G--AA-A--A-----C--------GG-G--AG-A-----T--C--------G--AGT-AGG-   6790 
USDA      6721  --A--TT-A---A-A-----------T--------A--A-----C--A-----T--T-----A---AGG-   6790 
UTCVM-H1  6721  --A--A--G--TA-A--T-----------A--G--C--A-----A--A--------G-----A--TG-GG   6790 
UTCVM-H2  6718  --G--A-----AA-G--T-----G-----AG-T-----C--------A--C-----A----G---TG-T-   6787 
UTCVM-NH2 6721  GGTTCGCTCCAGCGTGCCTGGGGTGACAAGAAAATTTCTAACACTGCCTTTATCACCACTGCCACCCTAA   6790 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 6791  C---------A         T-GG-A--TA-C--T--A--T-----AA----A--T-CTA-A--------   6851 
UTCVM-NH3 6791  A--AG—TTCT          ----GC--A-CC---GTA--T--TGCAA----AC-TA-T----AC-----   6851 
USDA      6791  ---AC----CA         --T-CA--A-CC--TGTG-------CCA-C-----T-CT----AC--G--   6851 
UTCVM-H1  6791  A---A-----T         T-G-TC--AA----T--A--T-GA--AGAT-----T-C---------G--   6851 
UTCVM-H2  6788  A---G------         ---G-A----CC-----A--T--T-CCA----AC-T-CT-----C-----   6848 
UTCVM-NH2 6791  GTGGTAACAACAACAACAAGATCAATCCCTGTAACACTATAGACCAGTCAAAGATCGTGGTGTTTCAAGA   6860 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 6852  --CA----C-AATCG---TACC--G-TA--G--------GC-T--T--A--C--A--------T-----A   6921 
UTCVM-NH3 6852  -GC---C----AG-CA--T--T-----G--T----TC--GC----GA-T--C--C--------A--C---   6921 
USDA      6852  --C------G--CGC------------A--T-----C--T------A-C-----------A--A-----A   6921 
UTCVM-H1  6852  T--T-----CAACGCT-----C--------T--T-TC---C----TACT-----G-----C--G-----A   6921 
UTCVM-H2  6849  ---T--C---AA-TCC--------G-----T----T---G---T-TG-T--C--C--T--G--G------   6918 
UTCVM-NH2 6861  CAACCATGTTGGAAAGGAAGTGCAAACCTCAGACGATACATTGGCCCTGCTTGGTTACACTGGCATTGGT   6930 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 6922  ---G----T--T--TG-----C-T--TA-A--G-----T--C--TGTC--T--C--G--------A--T-   6991 
UTCVM-NH3 6922  ---G----A--T--A-TG--C--A---AAA--G--A-----C----TC--A-----------AA-C--T-   6991 
USDA      6922  ---G-A--G--T--AG----C------A----C--------C--TGTA--G--A--------G-----C-   6991 
UTCVM-H1  6922  ---G-A--A--T--AG-CAT-C----TA----G-----T--C--TGTGT-A-----------C--A--T-   6991 
UTCVM-H2  6919  ---G-A--AG-T--TG----C------AAA-----T-----C---GTG--G--A-----------A--T-   6988 
UTCVM-NH2 6931  GAGCAGGCCATCGGGTCTGATAGGGACCGGGTTGTGCGCATTAGCACTCTCCCTGAAACTGGTGCTCGAG   7000 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 6992  -T--A--------C-----------A--------C--G--A--C--------C--A-----A-----A--   7061 
UTCVM-NH3 6992  ----C--T--T--C--------T-----TAGT-----G--A--G-----G-----------------AA-   7061 
USDA      6992  -T--C-----T--C--C--T-----------T------C-A--T-----G-----A-----A-----G--   7061 
UTCVM-H1  6992  -T--A--------C--A-----------TG-A--G---C----C---------G-TGA---A-----G--   7061 
UTCVM-H2  6989  -T--A--T--------C-----------------G--GC-T--------T--C--T--C--------G--   7058 
UTCVM-NH2 7001  GCGGTAACCACCCAATTTTCTACAAGAACTCCATTAAATTGGGATATGTAATTAGGTCTATTGATGTCTT   7070 
                                                                                       
                         .         .         .         .         .         .         .       
UTCVM-NH1 7062  ------T--G-----A--T-----T--G--AC----T--T--C--C-----T--AT-------C--A---   7131 
UTCVM-NH3 7062  G--C--T-----TC-A-----G--T--G--AC-G--A--T---A-C---TC-T-A--C------------   7131 
USDA      7062  ---C--T------C-------A--TC----AC----C--C---A-C--T--T-----------------C   7131 
UTCVM-H1  7062  ---C--T-----TC-A-----A--T--G--AC-------C---A-C---T-G--A--C--A--C--C--C   7131 
UTCVM-H2  7059  T--C--C--------A--------A--G--A-----C--T-----------G--T--------C--A---   7128 
UTCVM-NH2 7071  CAATTCGCAAATCTTGCACACTTCCAGACAGTTATCGCTAAATCATTACCTACTCCCACCTGATTCTTTT   7140 
                                                                                        
                         .         .         .         .         .         .         .       
UTCVM-NH1 7132  -----------G--C-C------T--------T--------C--A--C--------------T-------   7201 
UTCVM-NH3 7132  -----T-----G--------T--TGC------T--------------------------C-----T----   7201 
USDA      7132  -----G--CC-G----C---T--T-----T--A--------C--A-----------------C-------   7201 
UTCVM-H1  7132  -----T--C--G--C--------T--C--A--T---------G-A--C-----CTC---------T----   7201 
UTCVM-H2  7129  -----------G--T-C------T--------T--------C--A--T-----C-A------A-----C-   7198 
UTCVM-NH2 7141  GCTGTCTATAGAATAATTGACTCAAATGGCTCGTGGTTTGATATTGGAATTGATAGTGATGGGTTCTCTT   7210 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 7202  -----------AA-AA-A-------------G------T-AA-------------------T--------   7271 
UTCVM-NH3 7202  --------A-----AATG-C--G---C-GAT---------A--------------------T--------   7271 
USDA      7202  ----C----CC--CAA-G----------G--G---------A-------------------T--------   7271 
UTCVM-H1  7202  -------------ATCTA-ACC----C-T-----------------------------------------   7271 
UTCVM-H2  7199  --------------CA-A-A------C-T--G-----------------------------T--------   7268 
UTCVM-NH2 7211  TTGTTGGTGTTTCTGGCTTTGGTAAATTAGAATTTCCTCTTTCTGCCTCCTACATGGGAATACAATTGGC   7280 
                                                                                        
                         .         .         .         .         .         .         .       
UTCVM-NH1 7272  ------T------------------------A-A-----A--A-------C-----T-----TT-A----   7341 
UTCVM-NH3 7272  ------TA-A--------C------------G-A--------A----------------G---T-A----   7341 
USDA      7272  ------T-----------A------------T-A--------A-------------TC-----T-A----   7341 
UTCVM-H1  7272  G--A--T--A--C------------------A-T--------A-------------------TT-A----   7341 
UTCVM-H2  7269  ---A--T-----------------------CT-A----T---A-------------TC-----T-A----   7338 
UTCVM-NH2 7281  AAAGATCCGGCTTGCCTCTAACATTAGGAGTCCCATGACTAAGTTATGAATTCAATATTAGGCCTGATTG   7350 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 7342  -C--------A-----A-----C-----C-----A-----G--------------------C-----A--   7411 
UTCVM-NH3 7342  -C-----A--------A-----C-----A-----A-----------------------------------   7411 
USDA      7342  ----------A--T--A-----C-----A-----A--A--------------------G-----G--A--   7411 
UTCVM-H1  7342  -C-----A--A--T--A-----C-----A-----A--C--------------------C--C--G-----   7411 
UTCVM-H2  7339  ----A--A--A--T--A-----C-----A-----A--------A-----G-----T--------------   7408 
UTCVM-NH2 7351  ATACTGTTACTAACACTATTGGTAAAGCTCAACAGATTGAATTGGACAAAGCTGCACTTGGTCAACAGCG   7420 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 7412  ---GC----A--G-----T--GAATC-T--T-----G--G--G-----------A---------------   7481 
UTCVM-NH3 7412  C--GC----AT-A-----A--GAA-C-T--T-----G--G--G--T-----G--A-----A---------   7481 
USDA      7412  G--C-----G--TAGG-----GAAT--A--T-AA------C-G-----------G-----A---------   7481 
UTCVM-H1  7412  ----C----A--T--------GAATC-C-----T-----GC-G--T--T-----A--C------------   7481 
UTCVM-H2  7409  C-----A--A--GAG-A-A--G-AT--A--T-----G--GC----T--------------A--------G   7478 
UTCVM-NH2 7421  TGAATTGGCTCTCCAACGCATTGGCTTGGACCGCCAAGCCTTAAACAACCAAGTTGAGCAGTTTAACAAA   7490 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 7482  -----A-----G--------------C--------A--A--T-----G--T--T----------------   7551 
UTCVM-NH3 7482  --------------------------------G--G--------A-----A--------T----------   7551 
USDA      7482  -----------G--------------T--------T--G---T-G--G--------A-----C-------   7551 
UTCVM-H1  7482  --------------------------T-----G--T--C--------G-----A-----G----------   7551 
UTCVM-H2  7479  --C-----------------------C--------A--G--T----------------------------   7548 
UTCVM-NH2 7491  ATTCTTGAGCAAAGGGTACAAGGCCCAATCCAATCCGTTCGCCTTGCACGCGCGGCTGGATTTAGGGTTG   7560 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 7552  ----------T--------T-----T--------T--------A---------C-G----------GG--   7621 
UTCVM-NH3 7552  -------------------T--G--T--------T-----G--A---------C-G----------GG--   7621 
USDA      7552  -------------------T-----T----------------------------------------G---   7621 
UTCVM-H1  7552  -------------------T--G-----------T--------A---------C-G----------GG--   7621 
UTCVM-H2  7549  -------------------T-----T-----------------A--------------T-------G---   7618 
UTCVM-NH2 7561  ACCCTTACTCATACACAAACCAAAACTTTTATGACGATCAATTGAATGCAATTAGACTATCATATAAAAA   7630 
                                                                    
                         .         .         .         .         .         .         
UTCVM-NH1 7622  ------------G-------G-G-AT-CC-TC-GGCTGC---A-C---GCCTAA--CCA-  7681 
UTCVM-NH3 7622  ---------G-A--AG-TTG--T-GGTCA-AT-TAT--CTT-GG--CGTCGCATTTGC-C  7681 
USDA      7622  -C---------A--------G-------------A-----T-TA----------------  7681 
UTCVM-H1  7622  ------------G------C--G-AT-CC-TT-GGCTGA----CCTTGGCGC-TAACCCC  7681 
UTCVM-H2  7619  -C-A----------------G--------C------A---AAT-----------------  7678 
UTCVM-NH2 7631  TTTGTTTAAAATTTGATCATATATCCCTTTGGGCTGCCGCGCCTGCGCCTAACCCCAGGG  7690 
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                         .         .         .         .         .         .         .     
UTCVM-NH1    1  ----------------------------------LY-R---SM-------------------SNI-----   70 
UTCVM-NH3    1  ----------------------------------LL-R--HVM-------------------NTI-----   70 
USDA         1  ------------N---------------------FY------M-------------------T-I-----   70 
UTCVM-H1     1  ----------N--------L---R----------FY-R---SL-V----------I------S-------   70 
UTCVM-H2     1  ----------------------------------FY------M------------T------N-I-----   70 
UTCVM-NH3    1  MSQTLSFVLKTHSVRKDFVHSVKLTLARRRDLQYIHNKLSRTIRAEACPSCASYDVCPNCTSGDVPDDGS   70 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1   71  --T----------T------------E----D--A------------------I------------V---   140 
UTCVM-NH3   71  --T--------V-T-----------T-----D--------------S------N----------------   140 
USDA        71  -IK---------RT-----------------D--------------A------ID---------------   140 
UTCVM-H1    71  --T----------T-----------------T--------------A------V----------------   140 
UTCVM-H2    71  -IN----------T---------------DST----I-S--------------ID-----------V---   140 
UTCVM-NH2   71  STMSIPSWEDVTKSSTYSLLLSEDTSDELCPEDLVNVAAHIRKALSTQSHPANAEMCKEQLTSLLVMAEA   140 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  141  -------STL------VT--------------------I-A---V--I-------------------E--   210 
UTCVM-NH3  141  -------STL----R-VT--------------------L--------I-S-----------------D--   210 
USDA       141  -------SAL------K---------------------I-------------------------------   210 
UTCVM-H1   141  --------TL---D-YKT-------------------KI-A------I------V------------E--   210 
UTCVM-H2   141  -------S--------QT--I-----------------I--------V------L------------E-Y   210 
UTCVM-NH2  141  MLPQRSRASIPLHQQHTAARLEWREKFFSKPLDFLLERVGVSKDILQTTAIWKIILEKACYCKSYGEQWF   210 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  211  N---R-IG-I----YS-----V-A------L--------L---------I-------------------V   280 
UTCVM-NH3  211  NV-----SVVSKI--S-------A------LI-------L-------S-I---------------V---V   280 
USDA       211  D--------I-S--GN-------A------L--------I---------I---------------I----   280 
UTCVM-H1   211  NT---E--KI-SY--N-------A-------M-------L---------I-------------------V   280 
UTCVM-H2   211  H------K-V-T--GT-----V-A-------M-------I---------I--------------------   280 
UTCVM-NH2  211  TAAKQKLREMKNFESDTLKPLIGGFIDGLRFLTVDNPNPMGFLPKLIGLVKPLNLAMIIDNHENTLSGWI   280 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1  281  V------------D--------L--G----LS--P--F-Q--N--M---A---S---------V------   350 
UTCVM-NH3  281  ----------G--D--------L--T---QL--LP----Q--G----------S----------------   350 
USDA       281  V-----------------VV--L--T-------------Q-------I-T-------------V------   350 
UTCVM-H1   281  V------------D-------ALV-G-----------F-Q-----I------------------------   350 
UTCVM-H2   281  V------------D-----V--L--G----LA---R---Q--N------A---S---------V------   350 
UTCVM-NH2  281  ITLTAIMELYNITECTIDIITSVITAFYDKIGKATKFYSCVKALFTGFRSEDVANSFWYMAAAILCYLIT   350 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  351  -------M-----T-----S------I-------------------------------------------   420 
UTCVM-NH3  351  ----------------S---------M-------------------------------------------   420 
USDA       351  ----------------S---------M-------------------------------------------   420 
UTCVM-H1   351  ----------------S--S------I-------------------------------------------   420 
UTCVM-H2   351  --L-------------S---------I----------A--------------------------------   420 
UTCVM-NH2  351  GLIPNNGRFSKIKACLAGATTLVSGIVATQKLAAMFATWNSESIVNELSARTVALSELNNPTTTSDTDSV   420 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1  421  ---------------V------------------------------------------------------   490 
UTCVM-NH3  421  ---------------V-----------------------------------K------------------   490 
USDA       421  ---------------V------------------------------------------------------   490 
UTCVM-H1   421  G--------------V------------------------------------------------------   490 
UTCVM-H2   421  -K-------------V------------------------M-------------P---------------   490 
UTCVM-NH2  421  ERLLELAKILHEEIKIHTLNPIMQSYNPILRNLMSTLDGVITSCNKRKAIARKRQVPVCYILTGPPGCGK   490 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1  491  ----------------------------------------------------------------------   560 
UTCVM-NH3  491  ----------------------------------------------------------------------   560 
USDA       491  ----------------------------------------------------------------------   560 
UTCVM-H1   491  ----------------------------------------------------------------------   560 
UTCVM-H2   491  ----H-------E----I----------------------------------------------------   560 
UTCVM-NH2  491  TTAAQALAKKLSDQEPSVINLDVDHHDTYTGNEVCIIDEFDSSDKVDYANFVIGMVNSAPMVLNCDMLEN   560 
 
Figure 4.2: complete amino acid sequences of ORF-1 for the six isolates of 
Feline Calicivirus used in this study. The sequence for UTCVM-NH2 isolate 
is shown; for the other isolates, only residues that differ from UTCVM-NH2 
are shown. The dots above the sequences are spaced every 10 residues
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                         .         .         .         .         .         .         .      
UTCVM-NH1  561  -------------------------------------------A----------A---------------   630 
UTCVM-NH3  561  ----------------------------------------------------------------------   630 
USDA       561  ----------------------------------------------------------------------   630 
UTCVM-H1   561  ----------------------------------------------------------------------   630 
UTCVM-H2   561  ----------------------A------------------------------SA---------------   630 
UTCVM-NH2  561  KGKLFTSKYIIMTSNSETPVKPSSKRAGAFYRRVTIIDVTNPLVESHKRARPGTSVPRSCYKKNFSHLSL   630 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1  631  ----------------------TI---------------------T---------E--SD---------S   700 
UTCVM-NH3  631  -----------------------I---------------------AV-----D-----S----------D   700 
USDA       631  -R---------------------I---------------------A----S----E--ND---------D   700 
UTCVM-H1   631  ----------D------------T---------------------V-------P----S-----------   700 
UTCVM-H2   631  -----------------------I--LL--S--------------T----S-------SD--------R-   700 
UTCVM-NH2  631  AKRGAECWCKEYVLDPKGLQHQSMKAPPPTFLNIDSLAQTMKQDFLLKNMAFEAEDGCAEHRYGFVCQQE   700 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  701  -----------I-V-L-----------A-S-----------D-P----------------A-------Q-   770 
UTCVM-NH3  701  -----------I-V-LG----------A-S-V---------G-P----------------A-------Q-   770 
USDA       701  ---------------L-----------A-N-----------E-P-----------S----A-------Q-   770 
UTCVM-H1   701  -----------I-V-L-----------A-N-V---------G-P-----Y----------A-------Q-   770 
UTCVM-H2   701  -I-----------T-L-----------A-P-V------I--D-P----R-------------------Q-   770 
UTCVM-NH2  701  EVETVRRLLNAVRARMNATFTVCVGPETSHSIGCTAHVLTPNETFNGKKFVVSRCNEASLSALEGNCVKS   770 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  771  ---I---N---V----------I--------------------------------S--------------   840 
UTCVM-NH3  771  -------N---V------R------------------------------------S-T------------   840 
USDA       771  ---I---N----------R-----------------------------------------Y--V------   840 
UTCVM-H1   771  -------N-------------------------------------------------T------------   840 
UTCVM-H2   771  ---------------------------------------------------------S------K-----   840 
UTCVM-NH2  771  ALGVCMSDKDLTHLCHFIKGKIVNDSVRLDELPANQHVVTVNSVFDLAWALRRHLTLAGQFQAIRAAYDV   840 
                                                                                          
                         .         .         .         .         .         .         .       
UTCVM-NH1  841  -----------------------------I------------------------------------S---   910 
UTCVM-NH3  841  ---------------------------------------------------------------V--SI--   910 
USDA       841  --A---V---------D------------I----V----------------------------V--S---   910 
UTCVM-H1   841  ----------------------------------------------------------------------   910 
UTCVM-H2   841  --A---V---------D-----------------------------------------------------   910 
UTCVM-NH2  841  LTVPDKIPAMLRHWMDETSFSDEHVVTQFVTPGGIVILESCGGARIWALGHNVIRAGGVTATPTGGCVRL   910 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1  911  -----Q----F--------------------T------------------------S---P---------   980 
UTCVM-NH3  911  -----Q-------------------------T------------------------S-HSS---------   980 
 USDA      911  -----Q-------------------------T------------------------S-V-P---------   980 
UTCVM-H1   911  -----Q----------F----------I---T------------------------S---P---------   980 
UTCVM-H2   911  -----T------L-H----------------T-------I----------------N KTA---------   979 
UTCVM-NH2  911  MGLSAPTMPWSEIFRELFSLLGRIWSSVKVSALVLTALGMYASRFRPKSEAKGKTKLKIGTYRGRGVALT   980 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1  981  ------------T-----------------------A------------S-L-D-F--------------   1050 
UTCVM-NH3  981  ------------T----M------------------A------------SRL-D-FD-------------   1050 
USDA       981  ------------T-----------------------A------------SRL-D----------------   1050 
UTCVM-H1   981  ------------T-----------------------A-------------RAGD----------------   1050 
UTCVM-H2   980  ------------T-----------------------A------------S-L-D-F--------------   1049 
UTCVM-NH2  981  DDEYDEWREHNASRKLDLSVEDFLMLRHRAALGADDNDAVKFRSWWNSRTKMANDYEDVTVIGKGGVKHE   1050 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1051  R----------------------------------------------V----------------------   1120 
UTCVM-NH3 1051  RV---A-R---------------------------------------V----------------------   1120 
USDA      1051  ----------------------------------------------------------------------   1120 
UTCVM-H1  1051  -------R-------I-------------------------------V----------------------   1120 
UTCVM-H2  1050  -------R---------------------------------------V------------------Y---   1119 
UTCVM-NH2 1051  KIRTNTLKAVDRGYDVSFAEESGPGTKFHKNAIGSVTDVCGEHKGYCIHMGHGVYASVAHVVKGDSFFLG   1120 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1121  ------------------------------------------------A--------V------------   1190 
UTCVM-NH3 1121  -----V------------H-----------------------------P--------V------------   1190 
USDA      1121  ------------------------------------------------A--------V------------   1190 
UTCVM-H1  1121  ------------------------------------------------A--------V------------   1190 
UTCVM-H2  1120  ------------------------------------------------P--------I------------   1189 
UTCVM-NH2 1121  ERIFDLKTNGEFCCFRSTKILPSAAPFFSGKPTRDPWGSPVATEWKPKMYTTTSGKILGCFATTSTETHP   1190 
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                         .         .         .         .         .         .         .       
UTCVM-NH1 1191  ----------------------------------------------------------------------   1260 
UTCVM-NH3 1191  -----------------------------------------N---------I------------------   1260 
USDA      1191  -------------------------------I--------R----------P------------------   1260 
UTCVM-H1  1191  -----------------------------------------N---S---F-E------------------   1260 
UTCVM-H2  1190  -----------------------------------------E----------------------------   1259 
UTCVM-NH2 1191  GDCGLPYIDDNGRVTGLHTGSGGPKTPSAKLVVPYVHIDMKTKSVTAQKYDVTKPDISYKGLICKQLDEI   1260 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1261  -V-----------------E-----------------------------------------I--------   1330 
UTCVM-NH3 1261  ---------------V---E--------------------------------D-----------------   1330 
USDA      1261  -------------------E----------------------------------ID--------------   1330 
UTCVM-H1  1261  ------------------FTD-------------------------------D--------I--------   1330 
UTCVM-H2  1260  ---------------V---E--------------------------------D--------I--------   1329 
UTCVM-NH2 1261  RIIPKGTRLHVSPAHTEDYQECSHQPASLGSGDPRCPKSLTAIVVDSLKPYCEKVEGPPHDVLHRVQKML   1330 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1 1331  -------------------------------------------T------P------S------------   1400 
UTCVM-NH3 1331  ------------------------------------------IT------P------S------------   1400 
USDA      1331  ------------------I------------------------V------P------S------------   1400 
UTCVM-H1  1331  ----A-----------T--------------------------I----N--------S------------   1400 
UTCVM-H2  1330  ------------------I------------------------I------P------S------------   1399 
UTCVM-NH2 1331  IDHLSGFVPMNISSETSMLSAFHKLNHDTSCGPYLGGRKKDHMANGEPDKQLLDLLSAKWKLATQGIALP   1400 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1401  ----I------------A-----------------------A--D----------V-----I-G------   1470 
UTCVM-NH3 1401  ----I------------A-----------------------A--D----------V--------S-----   1470 
USDA      1401  ----I------------Y--------------------------D----------V-------G------   1470 
UTCVM-H1  1401  ----I--------I---QD-------------------------D-----------------------V-   1470 
UTCVM-H2  1400  ----I------------Q--------------------------D----------V-------G------   1469 
UTCVM-NH2 1401  HEYTFGLKDELRPVEKVSEGKRRMIWGCDVGVATVCAAAFKGVSYAITANHQYGPIQVGINMDSPSVEAL   1470 
                                                                                        
                         .         .         .         .         .         .         .       
UTCVM-NH1 1471  Y----------------------------------------------A---------V------------   1540 
UTCVM-NH3 1471  Y----------------------------------------------T-------I--------------   1540 
USDA      1471  Y----A-----------------------------------------A----------------------   1540 
UTCVM-H1  1471  Y----------------------------------------------T-------I--------------   1540 
UTCVM-H2  1470  Y---------------------------S------------------V------------------T---   1539 
UTCVM-NH2 1471  FQRIKSAAKVFAVDYSKWDSTQSPRVSAASIDILRYFSDRSPIVDSASNTLKSPPVAIFNGVAVKVSSGL   1540 
                                                                                         
                         .         .         .         .         .         .         .      
UTCVM-NH1 1541  -----------------------V------N---------S--M------------M-F--V--------   1610 
UTCVM-NH3 1541  -----------------------M------N------------M------------M-X--V--------   1610 
USDA      1541  -----------------------------RN---------S--ML---------L-T-F--V--------   1610 
UTCVM-H1  1541  ----------------M--------A---RQ---------S--M------------T-F----G------   1610 
UTCVM-H2  1540  ------------------------------N---------S--M------------M-F--V--------   1609 
UTCVM-NH2 1541  PSGMPLTSVINSLNHCLYVGCAILQSLEAKAIPVTWNLFSTFDIMTYGDDGVYMFPIMYASISDQIFGNL   1610 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1611  -A----------T---------E-------------H-----------------I---------N---T-   1680 
UTCVM-NH3 1611  -A-----------I--------E-------------------------------I---------T---T-   1680 
USDA      1611  -A--------------------E-------------H-----------T-----I---------T---T-   1680 
UTCVM-H1  1611  -A--------------------E-------------N-----------------I----T---QT---T-   1680 
UTCVM-H2  1610  -A--------------------E---------M---H-V---------L-----I---------T---T-   1679 
UTCVM-NH2 1611  SSYGLKPTRVDKSVGAIEPIDPDSVVFLKRTITRTPQGIRGLLDRSSIIRQFYYVKGENSDDWKSPPKHI   1680 
                                                                                         
                         .         .         .         .         .         .         .       
UTCVM-NH1 1681  --------------------S--Y----K---K-----G------S-T---E----------------NM   1750 
UTCVM-NH3 1681  --------------------Q--Y---LK--QK---------D--S-S---E----------------NM   1750 
USDA      1681  -QA-----------------V--Y-R--K---K-----G--L-V-N-NL--EQ--N--S---------SL   1750 
UTCVM-H1  1681  --------------------T--Y---LK--IK-----G------D-N---E------------C---NM   1750 
UTCVM-H2  1680  -AV-----------------V--Y----K---K---C-N------N-H---E----L-------T-----   1749 
UTCVM-NH2 1681  DPTSRGQQLWNACLYASQHGLEFFNKVYRLAERAVEYEELHFEPPTYASALDHYNSQFNGVEARSDQIDS   1750 
                                                                                         
                         .            
UTCVM-NH1 1751  --V----------  1763 
UTCVM-NH3 1751  -DA----------  1763 
USDA      1751  -DV----------  1763 
UTCVM-H1  1751  -DA----------  1763 
UTCVM-H2  1750  ---A---------  1762 
UTCVM-NH2 1751  SGMTALHCDVFEV  1763 
 
Figure (4.2) continued 
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the capsid protein, and the ORF3 encodes a minor protein with unknown 
function. The length of ORF1 was constant in most isolates (5308 
nucleotides encoding 1763 amino acids). Two exceptions were 
encountered: FCV isolate UTCVM-H had a deletion mutation of three 
nucleotides (nucleotides 2928-2930 of the ORF1), and FCV isolate 
CFI/68 had a deletion mutation of a three nucleotides (nucleotides 1802-
1804 of the ORF1) (figure 4.2). 
The polyprotein encoded by ORF1 is cleaved into six proteins. 
These proteins are called p5.6, p32, p39 (NTPase), p30, p13 (VPg), and p 
76 (proteinase-polymerase) respectively 136. Except for an insignificant 
change of the cleavage site between P39 (NTPase) and P30 at amino acid 
residue 686, the cleavage sites of these proteins among isolates were 
conserved. The cleavage site between P39 (NTPase) and P30 was 
aspartic acid in isolates: UTCVM-NH2, UTCVM-NH3, UTCVM-H1 and 
UTCVM-H2, whereas it was glutamic acid in isolates, UTCVM-NH1 
and USDA. 
The capsid gene protein is located in the middle of the genome and 
is transcribed by both the genomic RNA and sub-genomic RNA 2.4 Kb. 
The capsid protein is encoded by the ORF2. In this study, it was 
predicted to have 668 amino acids in all isolates except UTCVM-NH2 
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which had three more amino acids in the hypervariable area E compared 
to the other isolates (figure 4.3). 
ORF3 encodes 106 amino acids representing the VP2 structural 
protein. Its start codon overlaps the stop codon of ORF2 (figure 4.4). 
The number of nucleotides in the 3’ untranslated region was 
variable, ranging from 44 nucleotides (USDA, UTCVM-H2 and 
UTCVM-NH2), to 46 nucleotides in UTCVM-NH1, to 48 nucleotides in 
UTCVM-H1 and to 52 in UTCVM-NH3. 
 Comparison of the entire genome sequence among isolates 
indicated 78.3-80.6% homology (table 4.2 and figure 4.5). Comparison of 
ORF1 nucleotide sequence indicated 77.8-80.7% homology (table 4.3), 
whereas similarities among capsid gene nucleotide sequences were 74.8-
81.1% among the FCV isolates used in this study (table 4.4). The ORF3 
nucleotide homology among isolates was 82.4-90.3% (table 4.5). The 
similarities of the deduced amino acids among the ORF1 ranged from 
90.3-95.9% (table 4.6). It was 88.3-94.3% for ORF2 (table 4.7) and 95.3-
100% for the ORF3 (table 4.8) among the isolates examined. The genetic 
analysis of the isolates revealed a very high homology of UTCVM-NH2 




                         .         .         .         .         .         .         .     
UTCVM-NH1    1  ------------D-----R---D--K--S----D---------------------Q---Q----------   70 
UTCVM-NH3    1  ------------D-------I----K--S----D------------------N-NQ---Q----------   70 
USDA         1  ------------D----IR---D--R--S-S--DK--L----D-----------NQ--------------   70 
UTCVM-H1     1  ------------D-----R-NV---E--S----DK-------------------S-A-------------   70 
UTCVM-H2     1  ------------D----IR------K---I---D---------------------Q---Q----------   70 
UTCVM-NH2    1  MCSTCANVLKYYGWDPHFKLVINPNNFLPVGFCSNPLMCCYPELLPEFGTVWDCDRSPLEIYLESILGDD   70 
 
                         .         .         .         .         .         .         .    
UTCVM-NH1   71  -----YE-I--S------DS--------------YI--E--KA---N--NF----------T--------   140 
UTCVM-NH3   71  --V--YE-I---------NE---L------I----I--E--KA---N---F----------T-----P--   140 
USDA        71  --S---E-I---------DE-----------------NQ--KA---N---F----------S--------   140 
UTCVM-H1    71  --S--HE-I---------DE-----------------N---RA---N---F----------T-----L--   140 
UTCVM-H2    71  -----Y--I---------DD--------------F--NE--K----S--SF----------T-----A--   140 
UTCVM-NH2   71  EWASTFDAVDPVVPPMHWSAAGKIFQPHPGVLMHHLIGKVAAGWDPDLPLIRLEADDGSITAPEQGTMVG   140 
 
                         .         .         .         .         .         .         .      
UTCVM-NH1  141  ----------A----T---------------------------------------------T--------   210 
UTCVM-NH3  141  -----------A-------------------------------------------------S--------   210 
USDA       141  ----------------------------------------------------------------------   210 
UTCVM-H1   141  -------S---A----------------------------------------------------S-----   210 
UTCVM-H2   141  ----Q------A-----S---------E------------T-----------------------S-----   210 
UTCVM-NH2  141  GVIAEPSAQMSTAADMATGKSVDSEWEAFFSFHTSVNWSTSETQGKILFKQSLGPLLNPYLEHLAKLYVA   210 
 
                         .         .         .         .         .         .         .      
UTCVM-NH1  211  -----------------------------I--------------------------T-------------   280 
UTCVM-NH3  211  -------XL---------------I----IE-------------------------T------N------   280 
USDA       211  ----VD------------------------N---------------------------------------   280 
UTCVM-H1   211  ----V----------------------------------------------D----T------N------   280 
UTCVM-H2   211  -----D---------------------------------------------------L----NS----I-   280 
UTCVM-NH2  211  WSGSIEVRFSISGSGVFGGKLAAIVVPPGVDPVQSTSMLQYPHVLFDARQVEPVIFSIPDLRSTLYHLMS   280 
 
                         .         .         .         .         .         .         .      
UTCVM-NH1  281  ----------------------S------L----------------------------------S-----   350 
UTCVM-NH3  281  ----------I-----------S--------------A------------------I-------S-----   350 
USDA       281  --------------------S-S-----------------------------------------S-----   350 
UTCVM-H1   281  ----------------------S-----------------------------------------S-----   350 
UTCVM-H2   281  ---------------------E----------------------------------I------RS-----   350 
UTCVM-NH2  281  DTDTTSLVIMVYNDLINPYANDANSSGCIVTVETKPGPDFKFHLLKPPGSMLTHGSVPSDLIPKTSSLWI   350 
 
                         .         .         .         .         .         .         .       
UTCVM-NH1  351  --------N--------------------------------T----VKES--------------------   420 
UTCVM-NH3  351  ---H-T---E--V----------------------------T--V-EKG-S---------S---------   420 
USDA       351  ---H-T-----------------------------------TI---EK--S-------M-S---------   420 
UTCVM-H1   351  ---H-T----------------------------------L------SG-------I-------------   420 
UTCVM-H2   351  ---H-T-----------------------------------TIN---KE--R--TAI-V-T-L-------   420 
UTCVM-NH2  351  GNRYWSDITDFVIRPFVFQANRHFDFNQETAGWSTPRFRPISVTISQQDGAKLGIGVATDYIVPGIPDGW   420 
 
                         .         .         .         .         .         .         .      
UTCVM-NH1  421  ------TD-T--------DST-N----PS---S-IS-V-----R----------------V--------G   490 
UTCVM-NH3  421  ---S-SDT---S------SGN-N--I-GAD--S--V-------RS---------------V-E-------   490 
USDA       421  ------EK-V-------A-GT-N-----KD--S-TV-Q--------------------------------   490 
UTCVM-H1   421  ---------T-------V-QNNS--A-KQA-ES-TS-E------S-------H-----------------   490 
UTCVM-H2   421  ------TV-T---K----SGNNS--L-RND-EN--V-------RS--------------D---------G   490 
UTCVM-NH2  421  PDTTIPGELIPAGDYAITNNIGDDITTATGYDTADIIKNNTNFKGMYICGSLQRAWGDKKISNTAFITTA   490 
 
                         .         .         .         .         .         .         .     
UTCVM-NH1  491  IVT-   --LE-S-----T--AI---T-ANRDT-I---------------E---A---------V-----   557 
UTCVM-NH3  491  VRNE   -S-S-S-V--AT-LI-Y--A--ETD-----V---I--------E---L---K-----I-----   557 
USDA       491  -R-D   -T-T-S-V--PT--A-Y--T---A----------I--------E---A---------V-----   557 
UTCVM-H1   491  -VD-   -NLI-S---G-D--A-------NA------V---T--------E---AI--------V-----   557 
UTCVM-H2   491  -VN-   -N-E-S----PT-LA-------KS------V--SV--------E-V-A---K-----V-----   557 
UTCVM-NH2  491  TLSGNNNNKINPCNTIDQSKIVVFQDNHVGKEVQTSDDTLALLGYTGIGEQAIGSDRDRVVRISTLPETG   560 
 
Figure 4.3: complete predicted amino acid sequences of ORF-2 for the 
six isolates of FCV used in this study. The sequence for UTCVM-NH2 
isolate is shown; for the other isolates, only residues that differ from 




                         .         .         .         .         .         .         .     
UTCVM-NH1  558  --------------------------------------------S---------T---------------   627 
UTCVM-NH3  558  T------------------------M--------------N-S--------------A------------   627 
UTCVM-H1   558  ----------------------------------------N-------------T---------------   627 
UTCVM-H2   558  ------------AM------GD------------------N----------------------V------   627 
USDA       558  -------------M------S---------------------------------T------------N--   627 
UTCVM-NH2  561  ARGGNHPIFYKNSIKLGYVIRSIDVFNSQILHTSRQLSLNHYLLPPDSFAVYRIIDSNGSWFDIGIDSDG   630 
 
                         .         .         .         .          
UTCVM-NH1  628  ------NNI-------T-------------------T----  668 
UTCVM-NH3  628  -----I-NV---I-----------------------A----  668 
USDA       628  -----A-NV-------T-------------------S----  668 
UTCVM-H1   628  -------SIP--------------------------T----  668 
UTCVM-H2   628  -------HI---------------------------S-I--  668 
UTCVM-NH2  631  FSFVGVSGFGKLEFPLSASYMGIQLAKIRLASNIRSPMTKL  671 
 
Figure (4.3) continued 
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                             .         .         .         .         .         .         .     
UTCVM-NH1    1  --------------------------------------MN------------------------------   70 
UTCVM-NH3    1  --------------------------------------MN------------------------------   70 
USDA         1  --------------------------------D---R-MN--Q---------------------------   70 
UTCVM-H1     1  --------------------------------------MN----------D-------------------   70 
UTCVM-H2     1  ------------------------------------R-MD------------------------------   70 
UTCVM-NH2    1  MNSILGLIDTVTNTIGKAQQIELDKAALGQQRELALQRIGLDRQALNNQVEQFNKILEQRVQGPIQSVRL   70 
                                                                                         
                         .         .         .               
UTCVM-NH1   71  ------------------------------R----M  106 
UTCVM-NH3   71  ------------------------------R----N  106 
USDA        71  ------------------------------R----N  106 
UTCVM-H1    71  ------------------------------R----M  106 
UTCVM-H2    71  ------------------------------R-----  106 
UTCVM-NH2   71  ARAAGFRVDPYSYTNQNFYDDQLNAIRLSYKNLFKI  106 
 
Figure 4.4: complete predicted amino acid of ORF-3 for the six isolates of feline 
calicivirus used in this study. The sequence for UTCVM-NH2 isolate is shown; for 
the other isolates, only residues that differ from UTCVM-NH2 are shown. The dots 




















Amino acid similarities 
Figure 4.5: average nucleotide homology and % amino acids similarities 
% among the 12 FCV isolates used in this study 
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F9  79.7 79.2 79.9 79.6 79.2 79.7 98.2 78.9 78.7 78.4 79.9 
F4 79.7  78.9 79.4 78.7 78.7 78.8 79.6 78.4 79.8 78.3 79.4 
F65 79.2 78.9  79.4 79.4 79.7 80.0 79.3 78.7 79.5 79.4 79.4 
FCV 
2024 
79.9 79.4 79.4  80.1 79.6 80.1 79.9 79.7 79.9 79.9 99.9 
Urbana 79.6 78.7 79.4 80.1  79.7 79.5 79.7 79.9 78.9 78.9 80.1 
CFI/68 79.2 78.7 79.7 79.6 79.7  80.6 79.2 79.0 79.0 79.4 79.7 
UTCV
M-NH1 
79.7 78.8 80.0 80.1 79.5 80.6  79.6 80.6 79.5 79.8 80.2 
UTCV
M-NH2 
98.2 79.6 79.3 79.9 79.7 79.2 79.6  79.0 78.6 78.4 79.9 
UTCV
M-NH3 78.9 78.4 78.7 79.7 79.9 79.0 80.6 79.0  78.6 78.4 79.7 
UTCV
M-H1 78.7 78.4 79.5 79.9 78.9 79.0 79.5 78.6 78.6  78.4 80.0 
UTCV
M-H2 78.4 78.3 79.4 79.9 78.9 79.4 79.8 78.4 78.4 78.4  79.8 
USDA 79.9 79.4 79.4 99.9 80.1 79.7 80.2 79.9 79.7 80.0 79.8  
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Table 4.3: nucleotide percentage similarities among the different FCV isolates; comparison of non 





















F9  79.4 79.3 79.9 79.5 78.9 79.7 98.4 79.4 79.3 78.6 79.9 
F4 79.4  78.5 79.0 77.8 78.4 78.7 79.2 79.4 80.2 78.0 79.1 
F65 79.3 78.5  79.7 79.4 79.6 80.1 79.3 79.1 79.5 79.3 79.7 
FCV 
2024 
79.9 79.0 79.7  80.3 79.8 80.6 79.9 80.3 80.5 80.2 99.9 
Urbana 79.5 77.8 79.4 80.3  79.8 79.6 79.5 80.2 79.4 79.2 80.4 
CFI/68 78.9 78.4 79.6 79.8 79.8  80.2 79.1 79.3 79.3 79.3 80.7 
UTCV
M-NH1 79.7 78.7 80.1 80.6 79.6 80.2  79.8 81.3 80.0 80.1 80.7 
UTCV
M-NH2 98.4 79.2 79.3 79.9 79.5 79.1 79.8  79.5 79.1 78.7 79.9 
UTCV
M-NH3 
79.4 79.4 79.1 80.3 80.2 79.3 81.3 79.5  79.3 79.6 80.3 
UTCV
M-H1 79.3 79.4 79.5 80.5 79.4 79.3 80.0 79.1 79.3  78.7 80.5 
UTCV
M-H2 78.6 78.0 79.3 80.2 79.2 79.3 80.1 78.7 79.6 78.7  80.2 
USDA 79.9 79.1 79.7 99.9 80.4 80.7 80.7 79.9 80.3 80.5 80.2  
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Table 4.4: nucleotide percentage similarities among the different FCV isolates; comparison of 





















F9  79.3 77.2 78.7 78.7 78.9 78.5 97.7 76.3 75.4 76.3 78.7 
F4 79.3  78.1 78.9 79.0 77.9 77.7 79.0 78.1 77.4 77.8 78.9 
F65 77.2 78.1  77.1 77.4 78.4 77.8 77.7 75.7 77.4 77.6 77.1 
FCV 
2024 
78.7 78.9 77.1  78.1 77.8 77.8 78.7 77.3 77.0 77.1 99.9 
Urbana 78.7 79.0 77.4 78.1  78.2 77.3 78.9 77.2 76.0 76.6 78.0 
CFI/68 78.9 77.9 78.4 77.8 78.2  81.1 78.1 76.9 77.1 78.5 77.9 
UTCV
M-NH1 78.5 77.7 77.8 77.8 77.3 81.1  78.0 77.1 76.3 77.8 77.8 
UTCV
M-NH2 97.7 79.0 77.7 78.7 78.9 78.1 78.0  76.4 75.6 76.0 78.7 
UTCV
M-NH3 
76.3 78.1 75.7 77.3 77.2 76.9 77.1 76.4  74.8 77.6 77.3 
UTCV
M-H1 75.4 78.1 77.4 77.0 76.0 77.1 76.3 75.6 74.8  76.0 77.1 
UTCV
M-H2 76.3 77.8 77.6 77.1 76.6 78.5 77.8 76.0 77.6 76.0  77.1 
USDA 78.7 78.9 77.1 99.9 78.0 77.9 77.8 78.7 77.3 77.1 77.1  
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F9  85.2 87.1 85.2 83.3 84.3 84.6 98.7 84.9 84.9 84.9 85.2 
F4 85.2  87.1 85.5 87.1 84.6 85.2 85.9 85.9 85.5 82.4 85.5 
F65 87.1 87.1  86.5 89.9 86.8 88.4 86.5 89.3 88.4 88.1 86.5 
FCV 
2024 
85.2 85.5 86.5  85.5 86.2 84.6 85.2 83.3 85.5 87.4 100.0 
Urbana 83.3 87.1 89.9 85.5  86.8 89.3 84.0 90.3 86.8 86.2 85.5 
CFI/68 84.3 84.6 86.8 86.2 86.8  84.6 84.9 87.4 84.9 84.9 86.2 
UTCV
M-NH1 84.6 85.2 88.4 84.6 89.3 84.6  84.6 88.7 89.3 85.2 84.6 
UTCV
M-NH2 98.7 85.9 86.5 85.2 84.0 84.9 84.6  85.5 84.9 85.5 85.2 
UTCV
M-NH3 
84.9 85.9 89.3 83.3 90.3 87.4 88.7 85.5  88.7 85.2 83.3 
UTCV
M-H1 84.9 85.5 88.4 85.5 86.8 84.9 89.3 84.9 88.7  84.0 85.5 
UTCV
M-H2 84.9 82.4 88.1 87.4 86.2 84.9 85.2 85.5 85.2 84.0  87.4 
USDA 85.2 85.5 86.5 
100.




Table 4.6: amino acid percentage similarities among the different FCV isolates; comparison of non 





















F9  91.7 93.0 94.8 95.3 94.1 94.7 99.6 93.9 94.4 94.3 94.8 
F4 91.7  90.3 91.8 91.0 90.4 91.8 91.7 91.0 92.4 90.8 91.9 
F65 93.0 90.3  93.7 93.0 92.5 93.4 93.2 92.3 93.4 92.7 93.8 
FCV 
2024 94.8 91.8 93.7  95.5 94.1 95.9 95.0 94.9 95.3 95.4 99.9 
Urbana 95.3 91.0 93.0 95.5  94.0 95.7 95.5 94.6 94.4 94.8 95.5 
CFI/68 94.1 90.4 92.5 94.1 94.0  94.0 94.2 93.0 93.9 93.6 94.2 
UTCV
M-NH1 94.7 91.8 93.4 95.9 95.7 94.0  94.8 95.8 95.2 95.1 95.8 
UTCV
M-NH2 99.6 91.7 93.2 95.0 95.5 94.2 94.8  94.0 94.6 94.4 95.0 
UTCV
M-NH3 
93.9 91.0 92.3 94.9 94.6 93.0 95.8 94.0  94.6 93.9 95.0 
UTCV
M-H1 
94.4 92.4 93.4 95.3 94.4 93.9 95.2 94.6 94.6  94.0 95.4 
UTCV
M-H2 94.3 90.8 92.7 95.4 94.8 93.6 95.1 94.4 93.9 94.0  95.3 
USDA 94.8 91.9 93.8 99.9 95.5 94.2 95.8 95.0 95.0 95.4 95.3  
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Table 4.7: amino acid percentage similarities among the different FCV isolates; comparison of 





















F9  91.5 90.4 90.6 93.0 91.9 90.9 98.1 89.4 89.8 88.3 90.7 
F4 91.5  91.3 91.9 94.3 91.5 91.8 91.3 91.5 90.1 90.0 92.9 
F65 90.4 91.3  91.8 92.1 91.8 91.2 90.7 90.1 90.4 90.3 91.8 
FCV 
2024 90.6 91.9 91.8  92.5 91.8 91.6 90.7 91.6 90.4 90.0 99.9 
Urbana 93.0 94.3 92.1 92.5  93.0 91.8 92.7 91.3 91.0 89.2 92.7 
CFI/68 91.9 91.5 91.8 91.8 93.0  93.4 91.8 89.1 90.4 89.5 91.9 
UTCV
M-NH1 
90.9 91.8 91.2 91.6 91.8 93.4  90.7 89.4 89.7 89.1 91.8 
UTCV
M-NH2 98.1 91.3 90.7 90.7 92.7 91.8 90.7  89.2 90.0 89.1 90.1 
UTCV
M-NH3 
89.4 91.5 90.1 91.6 91.3 89.1 89.4 89.2  89.4 88.9 91.8 
UTCV
M-H1 
89.8 90.1 90.4 90.4 91.0 90.4 89.7 90.0 89.4  89.7 90.1 
UTCV
M-H2 88.3 90.0 90.3 90.0 89.2 89.5 89.1 89.1 88.9 89.7  90.0 


























F9  95.3 96.2 95.3 97.2 97.2 97.2 100.0 97.2 97.2 97.2 95.3 
F4 95.3  98.1 95.3 97.2 97.2 96.2 95.3 97.2 96.3 95.3 95.3 
F65 96.2 98.1  97.2 99.1 99.1 98.1 96.2 99.1 98.1 96.2 97.2 
FCV 
2024 95.3 95.3 97.2  98.1 98.1 97.2 95.3 98.1 97.2 97.2 100.0 
Urbana 97.2 97.2 99.1 98.1  100.
0 
99.1 97.2 100.0 99.1 97.2 98.1 
CFI/68 97.2 97.2 99.1 98.1 100.0  99.1 97.2 100.0 99.1 97.2 98.1 
UTCV
M-NH1 





95.3 96.2 95.3 97.2 97.2 97.2  97.2 97.2 97.2 95.3 
UTCV




0 99.1 97.2  99.1 97.2 98.1 
UTCV
M-H1 97.2 96.3 98.1 97.2 99.1 99.1 100.0 97.2 99.1  97.2 97.2 
UTCV
M-H2 
97.2 95.3 96.2 97.2 97.2 97.2 97.2 97.2 97.2 97.2  97.2 
USDA 95.3 95.3 97.2 
100.





The phylogenetic tree based on the complete genome nucleotide 
sequence revealed that all FCV isolates belong to the same genotype 
regardless of geographical origin or clinical signs (figure 4.6). The 
phylogenetic analysis, based on the complete genome nucleotide sequences, 
revealed that isolates F9 and UTCVM-NH2 segregate together as a result of 
a high degree of nucleotide sequence similarities. The only difference 
appears to be a few point mutations. Similarly, FCV2024 and USDA also 
segregate together. F9 and UTCVM-NH2 had a high degree of similarity of 
the base sequences (more than 99%) and they segregate together in 
phylogenetic analysis. The latter observations suggest that F9 and UTCVM-
NH2 are virtually identical. The same conclusion was made with USDA and 
FCV2024 isolates. Both cases might represent the same virus with a few 
point mutations. UTCVM-H2 and CFI/68 isolates grouped together as a 
result of a three-nucleotide deletion in the ORF1, which is considered a 
conserved area. 
Phylogenetic trees based on nucleotide sequences and deduced amino 
acid sequences of the six different proteins of ORF1 (figures 4.7, 4.8 and 




Figure 4.6: phylogenetic tree based on the nucleotide 
sequence of the complete genome among FCV isolates 

















Figure 4.7: phylogenetic tree based on the amino acid 














Figure 4.8: phylogenetic tree based on the amino acid 















Figure 4.9: phylogenetic tree based on the amino acid 
sequences of; E) p13 (VPg) and F) p76 (proteinase-
polymerase) of the ORF1 
 
 75 
genotype. There was no closer relationship of any given FCV isolate to 
another FCV isolate. This applies also to the two FCV isolates associated 
with the hemorrhagic disease. 
The phylogenetic tree based on the nucleotide sequence of the capsid 
protein gene (figure 4.10), strongly supported the finding that all the FCV 
isolates included in the study belong to the same genotype. The latter tree 
segregated F9 and UTCVM-NH2 isolates together because these two 
isolates represent the same virus (both have 9 nucleotide insertions in the 
hypervariable region E of the capsid protein gene). 
The two isolates associated with hemorrhagic disease could not be 
distinguished from each other by phylogenetic analysis of the complete 
genome, ORF1 (using the 6 different cleaved proteins), ORF2 and ORF3 
using both nucleotide and deduced amino acid sequences. The exception was 
using the area containing amino acids 426-445 of the capsid protein, (figure 
4.11). 
Sequence data was not available for the entire genome of the FCV 
hemorrhagic-like disease isolates other than UTCVM-H1 and UTCVM-H2, 
but nucleotide sequences of a portion of the capsid E area were used to 










Figure 4.10: phylogenic tree based on the nucleotide 
sequence of the capsid protein gene among FCV isolates 











Figure 4.11: phylogenic tree based on the amino acids 
residues 426-445of the capsid protein among FCV isolates 
used in this study. 
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Using hypervariable E area to create a phylogenetic tree revealed one 
genotype of FCV. In contrast, a phylogenetic tree created by using deduced 
amino acid residues 426-445 of the capsid protein gene showed clustering of 
UTCVM-H1 and UTCVM-H2 along with the hemorrhagic-like isolate Kaos 
(figure 4.11).  
Neutralization pattern 
 Seven serum samples were used to determine the neutralization 
pattern against four of the FCV isolates (UTCVM-H1, UTCVM-H2, 
UTCVM-NH1 and USDA). Five samples were from convalescent cats in the 
cattery from which UTCVM-H1 had been isolated. The five sera had very 
high antibody titers against the homologous isolate (UTCVM-H1), but not 
against other isolates. The titer against the UTCV-H1 was greater than 2560 
in all of these sera while it was not greater than 320 against any of the other 
FCV isolates. A sample from a cat infected with UTCVM-H2 had the 
highest antibody titer (320) to homologous isolate (UTCVM-H2), and it did 
have cross reactivity with UTCVM-H1 at lower titer (80) while it had very 
low neutralization titer to the other two isolates associated with classical 
disease. The antibody titers for each sample against the four FCV isolates 




Table 4.9: neutralization titer of the serum sample from cats infected with 
FCV associated with hemorrhagic-like disease against four FCV isolates 
 
  Neutralization titer 
Serum samples UTCVM-H1 UTCVM-H2 UTCVM-NH1 USDA 
UTCVM-H1# 1 > 2560 40 10 40 
UTCVM-H1 # 2 > 2560 80 20 40 
UTCVM-H1 # 3 > 2560 40 < 10 40 
UTCVM-H1 # 4 640 < 10 < 10 < 10 
UTCVM-H1 #5 > 2560 80 20 320 
UTCVM-H2 #1 80 320 10 10 




 The serum samples from the UTCVM-H1 outbreak were tested for 
antibodies by indirect immuno-fluorescence. All the samples reacted with 
high titer against all the FCV isolates (table 4.10). The results suggested that 
all cats infected with UTCVM-H1 had a high a cross-reactive antibody titer 
when the whole virus particles were used as antigen. 
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Table 4.10: immunofluorescence antibody titers of the serum sample from 
cats infected with FCV associated with hemorrhagic-like disease against 







type D (F9) 
USDA 
serum samples     
UTCVM-H1 #1 2560 2560 1280 1280 
UTCVM-H1 #2 2560 2560 5120 10240 
UTCVM-H1 #3 5120 2560 5120 640 
UTCVM-H1 #4 5120 5120 10240 10240 
UTCVM-H1 #5 5120 10240 10240 10240 
UTCVM-H1 #6 10240 2560 5120 2560 
UTCVM-H1 #7 5120 5120 10240 10240 
UTCVM-H1 #8 2560 1280 2560 2560 
UTCVM-H1 #9 1280 1280 1280 1280 
UTCVM-H1 #10 320 640 320 1280 





Changes of viral pathogenesis due to genomic mutation have been 
reported. Molecular analyses of virus isolates associated with altered 
pathogenesis defined various genomic alterations. These genomic alterations 
included insertions of cellular sequences, duplications of viral sequences, 
genomic  rearrangements (bovine virus diarrhea virus), deletion mutation 
(swine coronavirus), and point mutation (parvovirus) 60,75, 121. On the basis  of 
fragmentary sequence data that exists on FCV associated with hemorrhagic-
like disease, no conclusive hypothesis has been made to explain the genetic 
basis of FCV pathogenesis 61,100,130. 
Bovine viral diarrhea virus (BVDV) is an RNA virus. Two biotypes of 
BVDV, distinguished by their effect on cell culture, are recognized; 
cytopathic (cp) and non-cytopathic (ncp) 47. The difference between these 
two biotypes is attributed to genetic mutations. These mutations are due to 
insertion mutations in specific  sites (p125/NS23 non-structural protein gene) 
of the viral RNA or point mutation within NS2 gene 75. The insertion 
mutation is a consequence of genetic recombination of bovine cellular RNA 
86,113,155 or rearrangement and duplication of viral RNA sequence 87,113,145 or, 
more interestingly, recombination of sequences from a vaccine strain 8. 
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While p125/NS23 non-structural protein gene has been expressed in both 
cytopathogenic and non-cytopathogenic BVDV, p80/NS3 (non-structure 
protein) has been expressed, exclusively by all cytopathogenic BVDV 37,104. 
In addition to p80/NS3 expression, p54/NS2 has been expressed exclusively 
in some, not all cytopathogenic BVDV 4,74. These mutations are the basis of 
a virulent disease (mucosal disease) developing in persistently infected 
animals and characterized by high case fatality with death occurring usually 
within two weeks 3. The recombinant virus is antigenically identical to the 
parent virus but the biotype changes (non-cytopathic to cytopathic) 141. The 
nucleotide sequence of the 5' untranslated region is the internal ribosome 
entry site and the translation initiation sequence, and is considered a virulent 
marker for different strains of BVDV 105,125. 
Canine parvovirus and feline panleukopenia virus have over 98% 
DNA homology but their antigenic and hemagglutination properties differ 
and each has a distinct host range. The differences have been attributed to 
some amino acid variations of the capsid protein (VP1 and VP2 proteins) 60. 
Another example of a pathogenicity changes due to genetic mutation is the 
porcine coronavirus associated with respiratory tract disease which likely 
originated from transmissible gastroenteritis virus (TGEV). A large deletion 
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in the 5'-region of the TGEV spike glycoprotein gene may have been 
responsible for a change in tissue tropism from gastrointestinal tract to 
respiratory epithelium.15,121 
Calicivirus infections associated with a hemorrhagic-like disease with 
high mortality rates have occurred in cat populations.61,100,130  FCV has been 
isolated from cats with fatal systemic infections and lesions attributable to 
vasculitis and severe necrotizing pneumonia. This novel presentation is 
similar to that observed with calicivirus infection of Rabbit Hemorrhagic 
Disease, and may represent an alteration in calicivirus tissue tropism in cats. 
Severe upper respiratory tract infection also was present in all reported 
outbreaks of the severe disease. Consequently, it is possible that FCV 
mutants with enhanced virulence may develop from a parent “classical” 
virus, in cats infected with the latter. Characteristic clinical signs were 
consistently reproducible when the FCV associated with hemorrhagic 
disease was experimentally administrated to research cats 100. Because the 
disease is not always accompanied by hemorrhagic lesions, it has been 
suggested to rename the disease as a “virulent systemic FCV” disease 
instead of “hemorrhagic-like disease” 61. The hemorrhagic-like disease was 
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an indication of the involvement of blood vessels resulting in vasculitis and 
edema.  
Virus neutralization assays were done in this study to determine the 
antigenic relationship of FCV isolates associated with hemorrhagic-like 
disease to one another and to other FCV isolates associated with classical 
disease. Not surprisingly, the pattern of neutralization revealed that the 
homologous virus induced the highest neutralizing antibody titers. High 
titers were observed in convalescent serum samples from cats infected with 
UTCVM-H1. In these cats, the neutralizing antibodies titers, in most cases, 
were greater than 2560 (table 4.9). These results are in agreement with 
previous reports 100,130. Neutralizing antibodies from cats infected with the 
two hemorrhagic isolates (UTCVM-H1 and UTCVM-H2) used in this study, 
had some cross-activities but titers against the other FCV isolates tested 
were relatively low. This suggests that these two virulent isolates share a 
degree of homology at the neutralizing epitope level but are distinct from the 
other isolates. As expected, the immuno-fluorescence assay that reacts with 
all structural and non-structural proteins, a group test, revealed that all the 
convalescent sera obtained from convalescent cats infected with UTCVM-
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H1 had very high antibody titers against all FCV isolates. This confirms 
extensive antigenic cross-reactivity of several antigens in all FCV isolates. 
In this study, the complete genome of two FCV isolates associated 
with hemorrhagic-like diseases and four FCV isolates associated with 
“classical” disease were sequenced. Data were analyzed to determine genetic 
diversity and to identify possible mutations in FCV isolates that may be 
correlated with disease manifestations. The sequences of the 5' and 3'  
untranslated regions were also determined because of the potential that these 
areas may affect viral pathogenesis and for differentiation of the isolates into 
different genetic subgroups. Sequence data for six additional isolates 
associated with “classical” disease from GenBank were included also in this 
study. 
The nucleotide homology of the complete genome among various 
isolates (with two exceptions) was constant, at about 80% (table 4.2). This  
suggests the existence of a randomly heterogeneous population of viruses 
which is in agreement with data from previous studies 48,150. The overall 
homogeneity existed in spite of isolate diversity (including clinical signs, 
geographical origin and date of isolation). Two FCV vaccine viruses (F9 and 
FCV2024) appeared to be identical to disease-associated field isolates 
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(UTCVM-NH2 and USDA respectively), suggesting that, in some 
circumstances, vaccine virus can produce disease. The overall length of the 
FCV viral genome was relatively constant and ranged from 7631 to 7643 
nucleotides, which was in agreement with published data on FCV isolates. A 
lack of clustering among the all FCV isolates was identified in this study, 
when the complete genome sequence was used for phylogenetic analysis. 
The phylogenetic tree suggested that FCV exists as a single diverse genotype 
which is in agreement also with previous reports 44,48. The phylogenetic 
analysis with nucleotide sequences of the complete genome nucleotide 
sequences failed to cluster the virulent isolates, UTCVM-NH1 and 
UTCVM-NH2, from the other FCV isolates. This contradicts the recent 
findings of Pesavento et al who speculated that the virulent systemic strains 
of FCV were genetically distinct from other FCV 102. However the latter 
study did not present any genetic data for this conclusion. 
The length of ORF1 was relatively constant and had 5305 to 5308 
nucleotides, which is in agreement with the previous reports on FCV isolates 
associated with classical disease 48,96,150.  The genetic homogeneity of the 
ORF1 among the FCV isolates used in this study was approximately 80% 
which is similar to homogeneity analysis of FCV sequence data previously 
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reported150 (table 4.3). The ORF1 encodes a polyprotein which is cleaved by 
viral-encoded proteinase into six non-structural proteins. The amino acid 
sequences at the cleavage sites of ORF1, proposed by recent studies, were 
conserved among FCV isolates included in this study 136,139. These findings 
suggest that all non-structural proteins are constant products in FCV isolates 
including the FCV isolates associated with hemorrhagic-like disease. The 
phylogenetic tree using nucleotide and amino acid sequences of each of 
these six ORF1 proteins showed that FCV isolates (including FCV produce 
both hemorrhagic-like and classical disease) used in this study belong to the 
same genotype (Fig 4.7, 4.8 4.9). The phylogenetic trees of these proteins 
showed no clustering of any kind of the FCV isolates. It is clear that, these 
phylogenetic analyses did not segregate the virulent isolates. Collectively the 
data on ORF1 suggest that the non-structural polyprotein of FCV is a 
conserved product among all FCV isolates and does not have an obvious 
role in the change of viral pathogenesis.  
Nucleotide sequences of the capsid protein gene of the various viruses 
had a homology of 74.8 to 81.1% (table 4.4) which reflects the variability of 
the capsid protein gene among the FCV isolates. The capsid protein gene is 
divided into six areas of variability, identified as A, B, C, D, E, and F 134. 
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The analysis of FCV isolates used in this study confirmed the existence of 
the same pattern. All FCV isolates, regardless the clinical disease produced, 
had a similar degree of sequence relatedness to one another over the 
majority of the capsid gene protein. In contrast, researchers, from Japan 
identified two genetic groups and an association of each to a geographical 
origin when a part of the capsid protein gene (area E through F) was used for 
phylogenetic analysis 128. In the present study, there was little apparent 
clustering of isolates associated with the virulent disease when amino acid 
residues 426 to 445 of the E region was used in phylogenetic analysis (figure 
4.11).  
The ORF3 encodes a protein, VP2, of unknown function 54,137. Its 
function, however, likely is not related to the viral pathogenicity as 
suggested by the high amino acid similarities of VP2 (95.3-100%) among 
different FCV isolates associated with a wide range of clinical diseases.  
Vaccination against FCV is a common practice. The F9 strain has 
been widely used for preparation of killed and attenuated vaccines. The 
vaccine is effective at preventing disease, but occasionally FCV can be 
isolated from vaccinated cats that develop disease 24,33. The nature and origin 
of FCV isolates causing disease in vaccinated cats have not been identified 
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33. Recent sequence studies of FCV isolates causing disease in vaccinated 
cats suggest these viruses are derived from a vaccine virus, based on very 
high nucleotide homology of the E hypervariable region (98-100% 
homology) with vaccine viruses 59,114. The results in the present study 
support this conclusion. The UTCVM-NH2, E region, had 94.2% nucleotide 
homology (92.9% with the deduced amino acids) to that of the F9 isolate 
while it was 97.7% for the whole capsid protein gene. The E region may be 
responsible for inducing isolate-specific neutralizing antibodies and 
therefore may contain the immunologically-relevant part of the capsid 
protein 153. Five out of seven amino acid differences in the capsid protein, 
between F9 and UTCVM-NH2, occurred in E region (amino acid residues 
426 to 520) and two out of five differences in amino acid residues 440-443 
of the predicted E region peptide. The latter may be responsible for change 
in viral pathogenicity because these differences occur in the putative 
neutralizing (and perhaps attachment) site. A recent study identified 
neutralizing antibodies that target amino acids residues 426 to 460 of the 
capsid protein 153. Immunity induced by the F9 vaccine may not protect 
against UTCVM-NH2 because of the differences in the predicted 
immunologically relevant peptides (amino acid residue 441 to 443).  
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The amino acid residues 435 to 444 of various “classical” FCV capsid 
proteins were compared to the same residues of FCV associated with 
hemorrhagic-like disease because it is the most variable amino acid stretch 
between the two syndromes. The two hemorrhagic isolates (UTCVM-H1 
and UTCVM-H2) and Kaos isolate (also a virulent isolate) have a similar 
point mutation replacing the amino acid asparagine with serine in position 
443 of the capsid protein. More interestingly, UTCVM-H1 and UTCVM-H2 
have the same sequence of amino acids at position 441 to 443 (NNS) which 
is a unique sequence found only in these two isolates. This mutation leads to 
an additional glycosylation site when compared to FCV isolates associated 
with “classical” disease (data not shown). The amino acid area unique to 
UTCVM-H1 and UTCVM-H2 was followed by two amino acid residues 
conserved among all FCV isolates investigated which suggests that this 
epitope has a role in virus neutralization and perhaps cell attachment and 
tropism changes. This hypothesis is in agreement with observations in a 
previous study which revealed that two closely-related FCV isolates, based 
on amino acid sequence of residues 439 to 441, had the highest cross 
neutralization titers 132. In the present study, a phylogenetic tree based on 
twenty amino acids (426-445) segregated the three FCV isolates associated 
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with hemorrhagic like disease (UTCVM-H1 and UTCVM-H2 and Kaos) in 
a separate clade when all viruses were compared (Fig 4.11). The latter tree 
also segregated F9 and CFI/68 isolates in a separate clade. This is in 
agreement with a previous report in which MAbs produced against amino 
acid residues 422-448 of the F9 isolate capsid protein cross reacted with 
CFI/68 FCV isolate 88. 
The extra glycosylation site for UTCVM-H1 and UTCVM-H2 found 
in the hypervariable area E, is present also (but in a different location), in 
other FCV isolates associated with hemorrhagic-like disease, including 
FCV-Ari and FCV cat 15. This is in disagreement with a previous report in 
which only one glycosylation site for FCV isolates was proposed; however, 
this work was done with “classical” FCV isolates only 132. The potential role 
of glycosylation sites in the capsid protein of non-enveloped viruses with 
respect to virulence is unclear and merits further investigation. 
It is likely that the viral changes producing an altered pathogenesis 
may be minor, even point mutations. After an infection, the mutation 
responsible for viral pathogenicity may be occurring in the E region and 
more specifically in residues 435-445. Further work is required to prove that 
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the twenty amino acid stretch within the E region of FCV may relate to 
relevant virus neutralization epitopes and virus virulence. 
In conclusion, nucleotide homology and predicted amino acid 
sequence similarities between the two hemorrhagic isolates, either when the 
complete genome or individual ORFs were compared, were no greater than 
when either virus was compared to any other strain of FCV. This suggests 
that each FCV isolate has a distinct and unique origin. However data from 
the hypervariable E region suggests that disease phenotype may have a 
genetic basis. Further work is required to identify regions of FCV genome 
with emphasis on the E hypervariable region that may relate to virulence 
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